COPD is a serious public health problem in the United States. In 2008, chronic lower respiratory diseases, of which COPD represents the principal component, became the third leading cause of mortality.^[@r1]^ Because smoking is the dominant risk factor for COPD and contributed to about 80% of COPD deaths in 2000 to 2004,^[@r2]^ much of this disease is potentially preventable. People with COPD experience worse health-related quality of life, more disabilities, and higher rates of comorbidities than people without COPD.^[@r3]‐[@r5]^ The direct economic cost attributable to COPD and asthma in 2008 has been estimated at \$53.7 billion in the United States.^[@r6]^ These costs include those for prescription medicines (\$20.4 billion), outpatient or office-based providers (\$13.2 billion), hospital inpatient stays (\$13.1 billion), home health care (\$4.0 billion), and ED visits (\$3.1 billion).

COPD consists of chronic bronchitis, emphysema, and small airways disease. This common lung disease is characterized by inflammation and thickening of the mucosae of the airways, weakening or destruction of alveolar walls, and excess mucus production. These mechanical and physiologic changes lead to airflow limitation with limited reversibility. Patients affected by this disorder may be asymptomatic or experience cough, dyspnea, wheezing, and chest tightness. With progression of the disease, dyspnea worsens and oxygenation impairment develops. As the capacity of the lung continues to decline, patients may have increasing difficulty in performing activities of daily living. Although the clinical course of COPD is variable, it is progressive in many patients. Increasingly, research is examining the relationships between COPD and comorbid disease.^[@r7],[@r8]^

The condition has a diverse etiology.^[@r4],[@r9]^ Although smoking is the chief cause of COPD in most populations, substantial proportions of COPD occur among nonsmokers.^[@r10]‐[@r12]^ Other important causes include indoor air pollution from burning of biomass, occupational exposures to a variety of dusts and smoke, asthma, and repeated respiratory infections. In addition, genetic causes, such as α~1~-antitrypsin deficiency, can result in emphysema.

In 2002, the Centers for Disease Control and Prevention (CDC) released the initial surveillance report about COPD that contained surveillance data through the year 2000.^[@r13]^ This report summarized data from national data systems regarding prevalence, physician outpatient visits, ED visits, hospitalizations, and mortality. Of note was that the age-adjusted mortality rate had increased from 1980 to 2000, especially in women. The current surveillance report seeks to characterize recent aspects of the burden of COPD by providing additional information from national datasets through 2011.

Materials and Methods
=====================

The following data sources were used to produce the estimates in this report: Behavioral Risk Factor Surveillance System (BRFSS) (2011), National Health Interview Survey (NHIS) (1999-2011), National Ambulatory Medical Care Survey (NAMCS) (1999-2010), National Hospital Ambulatory Medical Care Survey (NHAMCS) (1999-2010), National Hospital Discharge Survey (NHDS) (1999-2010), death certificate data from the National Vital Statistics System (NVSS) (1999-2010), and Medicare Part A hospital claims administrative data (1999-2010). We did not include data from the National Health and Nutrition Examination Survey in this report because data from NHIS has commonly been used to provide national estimates of the prevalence of COPD. Furthermore, prevalence estimates of obstructive impairment using recent National Health and Nutrition Examination Survey data have been published.^[@r14]^ Except for Medicare hospital claims, the data presented in this report are limited to adults aged ≥ 25 years, to remain consistent with the prior surveillance report. Because all the data that were used in the analyses are freely available in the public domain, our study was exempt from human subject review.

Behavioral Risk Factor Surveillance System
------------------------------------------

BRFSS data from 2011 were used to estimate the state specific and US prevalence of COPD. An annual sample representing the noninstitutionalized US adult population aged ≥ 18 years in each state was selected by state health departments in collaboration with the CDC using a complex multistage sampling design.^[@r15]^ Data from 475,616 respondents aged ≥ 25 years were analyzed for this report. The BRFSS is a random-digit-dialed telephone survey of landline and cellphone households, and one adult is selected for the telephone interview. The median survey response rate in 2011 for all states and the District of Columbia was 49.7% and ranged from 33.8% to 64.1%. The median cooperation rate (percentage of people who completed interviews among all eligible contacted people) was 74.2% and ranged from 52.7% to 84.3%. The following question was used to define COPD: "Have you ever been told by a doctor or other health professional that you have chronic obstructive pulmonary disease (COPD), emphysema, or bronchitis?" An affirmative response was defined as physician-diagnosed COPD. Demographic information was self-reported.

National Health Interview Survey
--------------------------------

NHIS data from 1999 to 2011 were used to estimate the prevalence of COPD.^[@r16]^ The NHIS is implemented annually by the National Center for Health Statistics, CDC. During each year, a sample representing the civilian, noninstitutionalized US population aged ≥ 18 years was selected by using a complex multistage sampling design that involves stratification, clustering, and oversampling. The universe of primary sampling units (PSUs) (single counties or groups of adjacent counties---or equivalent jurisdictions---or metropolitan area) is organized into strata from which a sample of PSUs representing areas is drawn. From substrata (census blocks or combined blocks) created in these selected PSUs, secondary sampling units are systematically selected. From each substratum, households with African American, Hispanic, and Asian (since 2006) were oversampled, and a sample of all other households was selected. Only one randomly selected adult per family was asked to participate in the Sample Adult questionnaire. Participants were visited in their homes, where US Census Bureau interviewers conducted a computer-assisted personal interview with the participants. The number of adult participants and the response rates of the surveys are summarized in e-Table 1. Data from adult respondents aged ≥ 25 years were analyzed for this report. The following two questions were used to define COPD: "Have you ever been told by a doctor or other health professional that you had emphysema?" and "During the past 12 months, have you been told by a doctor or other health professional that you had chronic bronchitis?" An affirmative response to one or both of these questions was defined as physician-diagnosed COPD for this report. Demographic information was self-reported.

National Ambulatory Medical Care Survey
---------------------------------------

NAMCS data from 1999 to 2010 were used to estimate the annual number of physician office visits with the first-listed diagnosis of COPD.^[@r17]^ The NAMCS is an annual, national probability sample survey of ambulatory visits to nonfederally employed office-based physicians conducted by the National Center for Health Statistics, CDC. Beginning in 2006, visits to Community Health Centers (CHCs) were also included. NAMCS used a multistage design that involved probability samples of PSUs, physicians within PSUs, and patient visits within practices. The first-stage sample included 112 PSUs. In each sample PSU, a probability sample of practicing nonfederal office-based physicians was selected from master files maintained by the American Medical Association and American Osteopathic Association. The final stage involved systematic random samples of office visits during randomly assigned 7-day reporting periods. Starting in 2006, a dual-sampling procedure was used to select CHC physicians and other providers. First, the traditional NAMCS sample was selected using the methods described previously. Second, information from the Health Resources and Services Administration and the Indian Health Service was used to select a sample of CHCs. Within CHCs, a maximum of three health-care providers were selected, including physicians, physician assistants, nurse practitioners, or nurse midwives. After selection, CHC providers followed traditional NAMCS methods for selecting patient visits. The physician-patient encounter or visit represents the basic sampling unit in NAMCS.

Data are collected by the physician or the physician's staff or by US Census Bureau field representatives. Information concerning race and ethnicity was based on the physician's knowledge of the patient or on the physician's or assistant's judgment rather than the patient self-report. The number of physician office visits and the physicians' response rates are shown in e-Table 2. Because the percent of office visit medical records that were missing race information ranged from 16.9% to 32.8% (e-Table 2), we used information for race (whites and blacks only) that was imputed by the National Center for Health Statistics.

Three visit diagnosis fields were available to participating physicians. A diagnosis of COPD was established from the *International Classification of Diseases, Ninth Revision, Clinical Modification* (ICD-9-CM) codes 490 (bronchitis not specified as acute or chronic), 491 (chronic bronchitis), 492 (emphysema), or 496 (chronic airway obstruction, not elsewhere classified, which includes COPD) for the first-listed diagnosis. Rates for office visits were calculated using US civilian population estimates provided in the data file documentation for each year (e-Table 3). SEs were produced with statistical software.

National Hospital Ambulatory Medical Care Survey
------------------------------------------------

NHAMCS data for the years 1999 to 2010 were used to estimate the number of ED visits for COPD.^[@r17]^ The NHAMCS is an annual, national probability sample survey of ambulatory visits made to nonfederal, general, short-stay hospitals in the US conducted by the National Center for Health Statistics, CDC. NHAMCS uses a multistage probability design with samples of PSUs, hospitals within PSUs, EDs plus clinics within outpatient departments, and patient visits within EDs and outpatient clinics. Sample hospitals are randomly assigned to 16 panels that rotate across 13 4-week reporting periods throughout the year. The initial sample frame of hospitals was based on the 1991 SMG hospital database now maintained by IMS Health Incorporated. Hospital staff or US Census Bureau field representatives performed data collection for NHAMCS. The annual number of patient record forms submitted by EDs is shown in e-Table 4.

The NHAMCS files contained three visit diagnosis fields. An ICD-9-CM code of 490-492 or 496 for the first-listed diagnosis was defined as an ED visit for COPD. Because the percentage of ED records that were missing race information ranged from 10.4% to 15.3% (e-Table 4), we used information for race (whites and blacks only) that was imputed by the National Center for Health Statistics. The US civilian population estimates that we used to calculate rates of ED visits were obtained from the data file documentation for each year (e-Table 3). SEs were produced with statistical software.

National Hospital Discharge Survey
----------------------------------

NHDS data from 1999 to 2010 were used to estimate the annual number of hospital discharges for COPD.^[@r18]^ NHDS is an annual survey of inpatient discharges from nonfederal, short-stay hospitals in the US conducted from 1965 to 2010 by the National Center for Health Statistics, CDC. Using the SMG Hospital Market Data File or its successors as the sampling frame, the NHDS samples inpatient discharges from nonfederal, general, short-stay hospitals located in the 50 states and the District of Columbia. A three-stage design has been used since 1988. Units selected at the first stage of sampling consisted of either hospitals or geographic areas, such as counties, groups of counties, or metropolitan statistical areas in the 50 states and the District of Columbia. Within sampled geographic areas, additional hospitals were selected. Finally, at the last stage, discharges were selected within the sampled hospitals using systematic random sampling. Data collection was performed with manual and automated systems. The annual number of sampled records and hospital response rates are provided in e-Table 5.

Using the first-listed diagnosis, hospital discharges for COPD were identified by using the ICD-9-CM codes 490-492 or 496 as the first-listed diagnosis or ICD-9-CM code 466-466.1 (acute bronchitis) if the first-listed diagnosis of acute bronchitis was accompanied by another listed diagnosis of COPD (490-492 or 496). The percent of hospital records missing race information ranged from 16.0% to 31.0% (e-Table 5). US civilian population estimates used to calculate hospital discharge rates were obtained from the NHDS data documentation (e-Table 6). Relative SEs were calculated from the following formula: RSE(X) = (a + b/X)^1/2^, where a and b represent coefficients provided in the data documentation, and X represents the number of discharges.

Medicare Part A Hospital Claims
-------------------------------

Medicare data from 1999 to 2010 were used to estimate the annual number of hospital discharges for COPD among Medicare enrollees aged ≥ 65 years. Hospitalization information from 100% of Medicare Part A hospital claims data were obtained from an administrative claims dataset maintained by the Centers for Medicare and Medicaid Services. Information was limited to approximately 10 million annual claims submitted for short-term fee-for-service hospital stays among Medicare enrollees aged ≥ 65 years residing in one of the 50 states or the District of Columbia in a given year. A hospital discharge for COPD was defined for a first-listed discharge diagnosis with ICD-9-CM codes 490-492 or 496---about 3% of annual Medicare claims. Few Medicare claims (\< 0.05%) were submitted for acute bronchitis (ICD-9-CM code 466-466.1) with concomitant COPD; therefore, we did not include these discharges in our analyses. Race/ethnicity information on the claims data for Medicare enrollees represents information provided by most Medicare enrollees at the time of enrollment into the Medicare system or is information updated for older enrollees. Less than 0.5% of COPD claims were missing race information. State of residence was also obtained from the claims data. Medicare enrollment records were obtained from the Centers for Medicare and Medicaid Services and were used as the denominator file to calculate hospital rates after restricting the denominator to Medicare enrollees who met all the following criteria on July 1 of any given year (alive, aged ≥ 65 years, entitled to Part A benefits, residing in one of the 50 states or the District of Columbia, and not enrolled in a managed care plan).

National Vital Statistics System
--------------------------------

The number of deaths with COPD as the underlying cause for the years 1999 to 2010 come from the NVSS and are made available from CDC's WONDER system (Compressed Mortality File).^[@r19]^ This interactive Web-based tool allows queries to obtain numbers of death for underlying causes, crude death rates, age-adjusted death rates, 95% CIs, and SEs for groups defined by various characteristics including year, place of residence (state, county, region, or division), sex, age group, race, and Hispanic origin.^[@r20]^ Data from the NVSS are based on information from all resident death certificates filed in the 50 States and the District of Columbia. Cause-of-death statistics presented in this report are classified in accordance with the *International Classification of Diseases, Tenth Revision* (ICD-10). ICD-10 codes J40-J44 were used to identify deaths from COPD as the underlying cause of death. These causes include chronic bronchitis (J40-J42), emphysema (J43), and other COPD (J44).

Mortality rates were calculated by using population estimates produced by the Bureau of the Census in collaboration with the National Center for Health Statistics.^[@r20]^ The 1999 population estimates are US Census Bureau bridged-race intercensal estimates of the July 1 resident population, based on the 1990 census and the bridged-race 2000 census. The 2000 and 2010 population estimates are April 1 modified 2000 and 2010 census counts with bridged-race categories, whereas the 2001 to 2009 population estimates are bridged-race intercensal estimates of July 1 resident populations, based on the year 2000 and the year 2010 census counts (released by CDC on October 26, 2012). Age-adjusted death rates for 2001 to 2009 may vary from previous reports because of the 2012 revision of the 2001 to 2009 population denominator estimates.

Data Analysis
-------------

SAS-callable SUDAAN (Research Triangle Institute) was used to obtain weighted US estimates and prevalence from NHIS and state-specific and US estimates and prevalence from BRFSS. SAS or SAS-callable SUDAAN analyses for data from NAMCS, NHAMCS, and NHDS were weighted to obtain national US estimates. SAS was also used to obtain the number of COPD hospital discharges from Medicare hospital claims. The reported numbers of deaths, age-specific death rates, and age-adjusted death rates from COPD were obtained from CDC WONDER.^[@r19]^ Estimates were produced for all adults aged ≥ 25 years as well as for groups defined by age (25-44, 45-54, 55-64, 65-74, and ≥ 75 years), sex, and race/ethnicity. Racial/ethnic categories varied between surveillance systems because of differences in Medicare definitions of race/ethnicity categories; absence of racial/ethnic information on many medical records abstracted for NAMCS, NHAMCS, and NHDS; or small numbers of NHIS respondents in some racial/ethnic categories in the population samples selected. Except for Medicare estimates, age-adjusted estimates were standardized to the 2000 standard US population aged ≥ 25 years using the direct method.^[@r21]^ Medicare estimates were age-standardized to the 2000 standard US population aged ≥ 65 years. Because of the well-known relationship between age and COPD and because of the aging of the US population, we calculated age-adjusted estimates of prevalence and rates. State-specific age-adjusted estimates for BRFSS prevalence, Medicare hospitalizations, and mortality for COPD were also obtained to examine geographic clustering of COPD burden.

The statistical significance of temporal trends for age-specific prevalence of COPD in NHIS was examined by using log-linear regression analysis with time as the independent variable; analyses for trends in the age-adjusted prevalence included age as a continuous variable. The statistical significance for linear trends in age-specific and age-adjusted rates of physician-office visits, ED visits, NHDS and Medicare hospitalizations, and mortality was examined using weighted least-squares regression, where the weights were the inverse of the squared SE.

Results
=======

Prevalence (BRFSS Telephone Survey)
-----------------------------------

After age adjustment, 6.5% of US adults (unadjusted prevalence, 6.8%) representing 13.7 million noninstitutionalized adults aged ≥ 25 years in 2011 were estimated to have a self-reported physician diagnosis of COPD based on a telephone survey ([Table 1](#t01){ref-type="table"}). The age-adjusted prevalence displayed a strong age gradient, and the age-adjusted prevalence was higher in women (7.3%) than in men (5.7%) and higher in American Indian/Alaska Natives (11.0%) than in non-Hispanic whites (6.9%), non-Hispanic blacks (6.5%), Hispanics (4.1%), and Asian/Pacific Islanders (2.5%). The age-adjusted prevalence varied between states ([Table 2](#t02){ref-type="table"}). The highest age-adjusted prevalence of COPD in 2011 was clustered in the southern states and along the Ohio River Valley ([Fig 1](#fig01){ref-type="fig"}).

###### 

---Estimated Number and Prevalence of Self-Reported, Physician-Diagnosed COPD (Ever COPD, Chronic Bronchitis, or Emphysema) Among Adults Aged ≥ 25 Years, by Race, Sex, and Age Group---United States, Behavioral Risk Factor Surveillance System, 2011

  Characteristics                  Estimated No.[^a^](#tfn1){ref-type="table-fn"}   Age-Adjusted,^[b](#tfn2){ref-type="table-fn"},[c](#tfn3){ref-type="table-fn"}^ %   Unadjusted, %[^c^](#tfn3){ref-type="table-fn"}
  -------------------------------- ------------------------------------------------ ---------------------------------------------------------------------------------- ------------------------------------------------
  Race/ethnicity                                                                                                                                                       
   White, non-Hispanic             10,460,000                                       6.9                                                                                7.6
   Black, non-Hispanic             1,418,000                                        6.5                                                                                6.4
   Hispanic                        1,030,000                                        4.1                                                                                3.6
   Asian/Pacific Islander          173,000                                          2.5                                                                                2.2
   American Indian/Alaska Native   247,000                                          11.0                                                                               11.5
   Other, non-Hispanic             397,000                                          11.2                                                                               11.3
  Sex                                                                                                                                                                  
   Women                           8,197,000                                        7.3                                                                                7.8
   Men                             5,681,000                                        5.7                                                                                5.8
  Age group, y                                                                                                                                                         
   25-44                           2,755,000                                        ...                                                                                3.4
   45-54                           2,913,000                                        ...                                                                                6.6
   55-64                           3,263,000                                        ...                                                                                9.2
   65-74                           2,719,000                                        ...                                                                                12.1
   ≥ 75                            2,227,000                                        ...                                                                                11.6
  Total                            13,724,000                                       6.5                                                                                6.8

Numbers for each variable may not add to total because of rounding.

Age-adjusted to the 2000 US standard population aged ≥ 25 y.

All relative SEs are ≤ 30%.

###### 

---Estimated Number and Prevalence of Self-Reported, Physician-Diagnosed COPD (Ever COPD, Chronic Bronchitis, or Emphysema) Among Adults Aged ≥ 25 Years, By State---United States, Behavioral Risk Factor Surveillance System, 2011

  State                  Estimated No.[^a^](#tfn4){ref-type="table-fn"}   Age-Adjusted,^[b](#tfn5){ref-type="table-fn"},[c](#tfn6){ref-type="table-fn"}^ %   Unadjusted, %[^c^](#tfn6){ref-type="table-fn"}
  ---------------------- ------------------------------------------------ ---------------------------------------------------------------------------------- ------------------------------------------------
  Alabama                330,000                                          9.9                                                                                10.4
  Alaska                 24,000                                           6.1                                                                                5.5
  Arizona                253,000                                          5.8                                                                                6.1
  Arkansas               171,000                                          8.1                                                                                8.9
  California             1,073,000                                        4.7                                                                                4.9
  Colorado               167,000                                          5.1                                                                                5.0
  Connecticut            155,000                                          6.1                                                                                6.5
  Delaware               35,000                                           5.4                                                                                5.8
  District of Columbia   20,000                                           5.0                                                                                4.9
  Florida                1,086,000                                        7.5                                                                                8.4
  Georgia                462,000                                          7.4                                                                                7.4
  Hawaii                 43,000                                           4.5                                                                                4.7
  Idaho                  58,000                                           5.7                                                                                5.9
  Illinois               549,000                                          6.4                                                                                6.6
  Indiana                390,000                                          8.9                                                                                9.3
  Iowa                   109,000                                          5.0                                                                                5.5
  Kansas                 134,000                                          6.9                                                                                7.3
  Kentucky               306,000                                          10.1                                                                               10.6
  Louisiana              213,000                                          7.0                                                                                7.3
  Maine                  79,000                                           7.5                                                                                8.5
  Maryland               239,000                                          6.1                                                                                6.2
  Massachusetts          283,000                                          6.0                                                                                6.4
  Michigan               574,000                                          8.2                                                                                8.8
  Minnesota              148,000                                          4.1                                                                                4.2
  Mississippi            170,000                                          8.6                                                                                9.0
  Missouri               353,000                                          8.3                                                                                8.9
  Montana                44,000                                           6.0                                                                                6.6
  Nebraska               65,000                                           5.2                                                                                5.5
  Nevada                 143,000                                          7.9                                                                                8.1
  New Hampshire          61,000                                           6.4                                                                                6.9
  New Jersey             329,000                                          5.3                                                                                5.6
  New Mexico             92,000                                           6.5                                                                                6.9
  New York               822,000                                          6.0                                                                                6.3
  North Carolina         458,000                                          6.9                                                                                7.3
  North Dakota           21,000                                           4.5                                                                                5.0
  Ohio                   646,000                                          7.9                                                                                8.4
  Oklahoma               225,000                                          8.6                                                                                9.3
  Oregon                 168,000                                          5.9                                                                                6.5
  Pennsylvania           626,000                                          6.7                                                                                7.3
  Rhode Island           49,000                                           6.5                                                                                7.0
  South Carolina         252,000                                          7.7                                                                                8.2
  South Dakota           31,000                                           5.2                                                                                5.9
  Tennessee              391,000                                          8.6                                                                                9.2
  Texas                  928,000                                          6.0                                                                                5.9
  Utah                   68,000                                           4.4                                                                                4.3
  Vermont                24,000                                           4.9                                                                                5.6
  Virginia               363,000                                          6.6                                                                                6.8
  Washington             205,000                                          4.4                                                                                4.5
  West Virginia          124,000                                          8.8                                                                                9.7
  Wisconsin              219,000                                          5.4                                                                                5.8
  Wyoming                25,000                                           6.2                                                                                6.7
  Total                  13,724,000                                       6.5                                                                                6.8

Numbers may not add to total because of rounding.

Age-adjusted to the 2000 US standard population aged ≥ 25 y.

All relative SEs are ≤ 30%.

![Age-adjusted prevalence (%) of self-reported physician-diagnosed COPD among adults aged ≥ 25 years, by state---United States, Behavioral Risk Factor Surveillance System, 2011.](chest_144_1_284_fig01){#fig01}

Prevalence (NHIS Interview Survey)
----------------------------------

During the period from 1999 to 2011, the estimated numbers ([Table 3](#t03){ref-type="table"}) and age-adjusted prevalence of COPD ([Table 4](#t04){ref-type="table"}) fluctuated. Prevalence increased among successive age groups up to age 65 years and older, and the age-adjusted prevalence was usually higher among non-Hispanic whites compared with non-Hispanic blacks or Hispanics. The annual age-adjusted prevalence was higher in women than in men ([Fig 2](#fig02){ref-type="fig"}). The highest age-adjusted prevalence for both men and women was observed in 2001. Despite substantial interyear variation in age-adjusted prevalence estimates, significant tests for linear trend suggested declines during 1999 to 2011 in the age-adjusted prevalence among all adults (*P* = .019) and adults aged 25 to 44 years (*P* \< .001).

###### 

---Estimated Annual Number of Adults Aged ≥ 25 Years With Self-Reported Physician-Diagnosed COPD (Lifetime Emphysema or Chronic Bronchitis During the Preceding 12 Months), by Race/Ethnicity, Sex, and Age Group---United States, National Health Interview Survey, 1999-2011

  Variable               1999        2000         2001         2002         2003        2004         2005         2006         2007        2008         2009         2010         2011
  ---------------------- ----------- ------------ ------------ ------------ ----------- ------------ ------------ ------------ ----------- ------------ ------------ ------------ ------------
  Race                                                                                                                                                                            
   White, non-Hispanic   8,193,000   8,792,000    10,034,000   8,449,000    8,050,000   8,792,000    8,751,000    9,105,000    7,789,000   9,275,000    9,902,000    9,153,000    9,038,000
   Black, non-Hispanic   773,000     969,000      1,177,000    1,127,000    958,000     937,000      1,049,000    1,149,000    889,000     1,036,000    1,178,000    1,227,000    1,433,000
   Hispanic              512,000     573,000      655,000      621,000      601,000     693,000      655,000      679,000      683,000     655,000      910,000      927,000      987,000
   Other, non-Hispanic   224,000     182,000      273,000      253,000      214,000     261,000      236,000      376,000      285,000     324,000      347,000      323,000      441,000
  Sex                                                                                                                                                                             
   Women                 6,126,000   6,717,000    7,550,000    6,514,000    6,168,000   6,750,000    6,677,000    6,891,000    5,849,000   7,266,000    7,682,000    7,066,000    7,658,000
   Men                   3,576,000   3,798,000    4,588,000    3,936,000    3,655,000   3,934,000    4,013,000    4,419,000    3,796,000   4,024,000    4,655,000    4,564,000    4,241,000
  Age group, y                                                                                                                                                                    
   25-44                 3,087,000   3,157,000    3,899,000    3,129,000    2,526,000   2,987,000    2,868,000    2,552,000    2,159,000   2,795,000    2,597,000    2,699,000    2,560,000
   45-54                 1,811,000   2,184,000    2,671,000    2,311,000    1,964,000   2,294,000    2,274,000    2,461,000    2,039,000   2,703,000    2,773,000    2,383,000    2,430,000
   55-64                 1,725,000   1,879,000    2,135,000    2,014,000    2,126,000   2,043,000    2,199,000    2,747,000    2,351,000   2,330,000    2,937,000    2,740,000    3,053,000
   65-74                 1,639,000   1,721,000    1,773,000    1,678,000    1,791,000   1,702,000    1,845,000    1,703,000    1,624,000   1,902,000    2,120,000    2,018,000    2,253,000
   ≥ 75                  1,439,000   1,573,000    1,661,000    1,318,000    1,414,000   1,658,000    1,504,000    1,847,000    1,473,000   1,560,000    1,910,000    1,790,000    1,604,000
  Total                  9,702,000   10,515,000   12,138,000   10,450,000   9,822,000   10,683,000   10,690,000   11,310,000   9,646,000   11,290,000   12,337,000   11,630,000   11,899,000

Numbers for each variable may not add to total because of rounding.

###### 

---Estimated Annual Prevalence of Self-Reported Physician-Diagnosed COPD (Lifetime Emphysema or Chronic Bronchitis During the Preceding 12 Months) Among Adults Aged ≥ 25 Years, by Race/Ethnicity, Sex, and Age Group---United States, National Health Interview Survey, 1999-2011

  Variable                                 1999   2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   *P* for Linear Trend
  ---------------------------------------- ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ ----------------------
  Race[^a^](#tfn7){ref-type="table-fn"}                                                                                               
   White, non-Hispanic                     6.1    6.6    7.5    6.2    5.7    6.3    6.1    6.3    5.4    6.4    6.7    6.1    6.0    .130
   Black, non-Hispanic                     4.3    5.4    6.3    6.0    5.0    4.8    5.2    5.4    4.2    4.6    5.3    5.5    6.2    .443
   Hispanic                                3.6    3.9    4.3    3.7    3.6    3.9    3.3    3.5    3.3    3.1    4.1    3.9    4.3    .805
   Other, non-Hispanic                     4.0    2.8    3.9    3.2    3.3    3.6    2.9    4.1    2.9    3.1    3.4    3.1    3.9    .626
  Sex[^a^](#tfn7){ref-type="table-fn"}                                                                                                
   Women                                   6.7    7.3    8.1    6.9    6.3    6.8    6.6    6.7    5.6    6.9    7.1    6.5    7.0    .136
   Men                                     4.6    4.8    5.6    4.8    4.3    4.5    4.6    4.9    4.1    4.3    4.9    4.7    4.3    .063
  Age group, y                                                                                                                        
   25-44                                   3.7    3.9    4.8    3.9    3.1    3.6    3.5    3.1    2.6    3.4    3.2    3.3    3.2    \< .001
   45-54                                   5.1    5.9    7.0    5.9    4.9    5.6    5.4    5.7    4.7    6.2    6.3    5.4    5.6    .655
   55-64                                   7.5    8.0    8.8    7.9    7.7    7.1    7.3    8.8    7.2    7.0    8.4    7.7    8.2    .929
   65-74                                   9.2    9.6    10.0   9.5    9.9    9.3    10.0   8.9    8.4    9.6    10.3   9.5    10.3   .566
   ≥ 75                                    9.8    10.6   11.0   8.6    8.8    10.2   9.1    11.1   8.7    9.0    11.1   10.3   9.0    .679
  Total[^a^](#tfn7){ref-type="table-fn"}   5.7    6.1    6.9    5.9    5.3    5.7    5.6    5.8    4.9    5.6    6.0    5.7    5.7    .019
  Total[^b^](#tfn8){ref-type="table-fn"}   5.6    6.0    6.9    5.9    5.3    5.7    5.6    5.9    5.0    5.8    6.2    5.8    5.9    .372

Annual prevalence per 100 population. All relative SEs are ≤ 30%.

Age-adjusted to the 2000 US standard population aged ≥ 25 y.

Unadjusted prevalence.

![Age-adjusted prevalence (%) of self-reported physician-diagnosed COPD among adults aged ≥ 25 years, by sex and year---United States, National Health Interview Survey, 1999-2011.](chest_144_1_284_fig02){#fig02}

Physician Office Visits (NAMCS)
-------------------------------

In 2010, there were an estimated 10.3 million (unadjusted, 516.1 per 10,000 US civilian population; age-adjusted, 494.8 per 10,000 US civilian population) physician office visits with a first-listed diagnosis of COPD among adults aged ≥ 25 years. The age-adjusted rate of office visits for COPD was higher among men than women in 2010 ([Fig 3](#fig03){ref-type="fig"}) and higher among whites than blacks during 2009 to 2010 ([Fig 4](#fig04){ref-type="fig"}). There was considerable temporal variability in the estimated number of physician-based office visits ([Table 5](#t05){ref-type="table"}). As expected for a chronic disease, age-specific rates for office visits for COPD increased substantially within each given year ([Table 6](#t06){ref-type="table"}), and age-specific rates declined during 1999 to 2010 among those aged 45 to 54 years (*P* = .033). No clear time trend was evident for age-adjusted rates among any group defined by sex or race ([Table 6](#t06){ref-type="table"}).

![Sex-specific age-adjusted rates (per 10,000 US civilian population) of physician office visits, ED visits, and hospital visits for COPD as the first-listed diagnosis among adults aged ≥ 25 years---United States, National Ambulatory Medical Care Survey, National Hospital Ambulatory Medical Care Survey, National Hospital Discharge Survey, 2010.](chest_144_1_284_fig03){#fig03}

![Race-specific age-adjusted rates (per 10,000 US civilian population) of physician office visits, ED visits, and hospital visits for COPD as the first-listed diagnosis among adults aged ≥ 25 years---United States, National Ambulatory Medical Care Survey, National Hospital Ambulatory Medical Care Survey, National Hospital Discharge Survey, 2009-2010.](chest_144_1_284_fig04){#fig04}

###### 

---Estimated Annual Number of Physician Office Visits for COPD as the First-Listed Diagnosis Among Adults Aged ≥ 25 Years, by Race, Sex, and Age Group---United States, National Ambulatory Medical Care Survey, 1999-2010

  Variable                                1999         2000        2001         2002         2003         2004         2005         2006         2007         2008        2009         2010
  --------------------------------------- ------------ ----------- ------------ ------------ ------------ ------------ ------------ ------------ ------------ ----------- ------------ ------------
  Race[^a^](#tfn9){ref-type="table-fn"}                                                                                                                                                
   White                                  9,138,000    6,996,000   9,907,000    13,800,000   10,485,000   10,034,000   12,684,000   11,236,000   8,853,000    9,009,000   11,434,000   8,527,000
   Black                                  ...          ...         ...          ...          ...          ...          ...          ...          ...          ...         ...          ...
  Sex                                                                                                                                                                                  
   Women                                  6,080,000    4,041,000   6,260,000    9,391,000    6,667,000    6,878,000    6,405,000    6,929,000    6,099,000    5,947,000   8,001,000    5,210,000
   Men                                    4,275,000    3,956,000   4,483,000    5,697,000    5,672,000    4,606,000    6,667,000    6,016,000    4,488,000    3,663,000   4,940,000    5,081,000
  Age group, y                                                                                                                                                                         
   25-44                                  1,784,000    1,446,000   1,850,000    3,022,000    2,709,000    2,126,000    2,106,000    1,301,000    1,913,000    1,902,000   1,649,000    ...
   45-54                                  1,295,000    ...         ...          1,970,000    2,405,000    1,599,000    ...          1,758,000    1,409,000    1,005,000   2,158,000    ...
   55-64                                  2,276,000    ...         ...          2,538,000    1,704,000    2,440,000    2,415,000    3,171,000    1,919,000    2,077,000   3,024,000    2,153,000
   65-74                                  2,854,000    2,175,000   2,563,000    3,878,000    2,871,000    2,499,000    3,349,000    3,418,000    3,191,000    1,895,000   2,303,000    3,191,000
   ≥ 75                                   2,147,000    2,084,000   2,920,000    3,680,000    2,649,000    2,820,000    3,522,000    3,298,000    2,154,000    2,730,000   3,808,000    3,431,000
  Total                                   10,355,000   7,997,000   10,743,000   15,087,000   12,339,000   11,484,000   13,072,000   12,945,000   10,586,000   9,609,000   12,941,000   10,291,000

Numbers for each variable may not add to total because of rounding. COPD includes ICD-9-CM codes 490-492 or 496. Ellipses indicate unreliable estimate (relative SE \> 30% and/or number of records \< 30). ICD-9-CM = *International Classification of Diseases, Ninth Revision, Clinical Modification.*

Data not available for other specific race groups.

###### 

---Estimated Annual Rate of Physician Office Visits for COPD as the First-Listed Diagnosis Among Adults Aged ≥ 25 Years, by Race, Sex, and Age Group---United States, National Ambulatory Medical Care Survey, 1999-2010

  Variable                                                                  1999      2000      2001      2002      2003      2004      2005      2006      2007      2008      2009      2010      *P* for Linear Trend
  ------------------------------------------------------------------------- --------- --------- --------- --------- --------- --------- --------- --------- --------- --------- --------- --------- ----------------------
  Race^[a](#tfn10){ref-type="table-fn"},[b](#tfn11){ref-type="table-fn"}^                                                                                                                           
   White                                                                    623.4     473.1     651.0     897.2     676.1     633.4     791.7     679.1     541.6     537.4     661.1     481.0     .585
   Black                                                                    ...       ...       ...       ...       ...       ...       ...       ...       ...       ...       ...       ...       ...
  Sex[^a^](#tfn10){ref-type="table-fn"}                                                                                                                                                             
   Women                                                                    660.2     432.4     647.4     955.5     678.8     679.0     622.1     656.2     587.7     557.3     726.3     458.3     .725
   Men                                                                      572.0     519.5     583.3     714.6     701.4     547.5     789.3     688.6     515.6     410.5     525.4     554.4     .233
  Age group, y                                                                                                                                                                                      
   25-44                                                                    216.2     176.3     223.0     364.8     329.5     258.9     256.8     158.5     234.2     234.0     203.8     ...       .082
   45-54                                                                    363.7     ...       ...       495.5     594.3     387.3     ...       409.5     323.7     228.4     488.0     ...       .033
   55-64                                                                    987.5     ...       ...       960.0     614.4     843.8     799.8     1,009.1   589.7     619.7     873.5     600.7     .826
   65-74                                                                    1,603.7   1,224.9   1,417.7   2,150.8   1,586.8   1,371.6   1,820.3   1,830.4   1,670.3   953.4     1,120.6   1,505.7   .264
   ≥ 75                                                                     1,464.0   1,393.7   1,867.6   2,309.7   1,636.7   1,716.1   2,102.2   1,946.0   1,257.2   1,573.2   2,189.8   1,936.1   .380
  Total[^a^](#tfn10){ref-type="table-fn"}                                   609.2     466.6     604.8     836.2     673.5     614.2     691.6     663.1     543.0     483.3     632.3     494.8     .541
  Total[^c^](#tfn12){ref-type="table-fn"}                                   596.4     456.2     594.5     824.5     668.0     614.2     689.9     674.1     545.8     490.1     654.6     516.1     .848

Annual rate per 10,000 US civilian population. COPD includes ICD-9-CM codes 490-492 or 496. Ellipses indicate unreliable estimate (relative SE \> 30% and/or number of records \< 30). See [Table 5](#t05){ref-type="table"} legend for expansion of abbreviation.

Age-adjusted to the 2000 US standard population aged ≥ 25 y.

Data not available for other specific race groups.

Unadjusted rate.

ED Visits (NHAMCS)
------------------

In 2010, there were an estimated 1.5 million (unadjusted rate, 73.6 per 10,000 US civilian population; age-adjusted rate, 72.0 per 10,000 US civilian population) ED visits with a first-listed diagnosis of COPD among adults aged ≥ 25 years. The age-adjusted rate of ED visits for COPD was higher among women than men in 2010 ([Fig 3](#fig03){ref-type="fig"}) and among blacks than whites during 2009 to 2010 ([Fig 4](#fig04){ref-type="fig"}). The estimated annual number of ED visits for COPD fluctuated ([Table 7](#t07){ref-type="table"}). There was a considerable increase each year in age-specific rates for ED visits with advancing age up to ages 65 years and older ([Table 8](#t08){ref-type="table"}), but there were no significant temporal trends during 1999 to 2010 in age-specific and age-adjusted rates for any group defined by age, race, or sex.

###### 

---Estimated Annual Numbers of ED Visits for COPD as the First-Listed Diagnosis Among Adults Aged ≥ 25 Years, by Race, Sex, and Age Group---United States, National Hospital Ambulatory Medical Care Survey, 1999-2010

  Variable                                 1999        2000        2001        2002        2003        2004        2005        2006        2007        2008        2009        2010
  ---------------------------------------- ----------- ----------- ----------- ----------- ----------- ----------- ----------- ----------- ----------- ----------- ----------- -----------
  Race[^a^](#tfn13){ref-type="table-fn"}                                                                                                                                       
   White                                   1,205,000   1,278,000   1,039,000   1,046,000   1,230,000   957,000     1,112,000   973,000     1,067,000   1,295,000   1,452,000   1,179,000
   Black                                   285,000     243,000     226,000     229,000     273,000     172,000     342,000     327,000     207,000     265,000     272,000     253,000
  Sex                                                                                                                                                                          
   Women                                   802,000     898,000     717,000     769,000     907,000     619,000     841,000     729,000     842,000     861,000     1,029,000   945,000
   Men                                     730,000     651,000     582,000     523,000     648,000     528,000     647,000     587,000     455,000     726,000     734,000     523,000
  Age group, y                                                                                                                                                                 
   25-44                                   448,000     481,000     488,000     418,000     372,000     356,000     492,000     314,000     397,000     358,000     446,000     388,000
   45-54                                   270,000     194,000     193,000     183,000     294,000     151,000     215,000     293,000     255,000     277,000     297,000     284,000
   55-64                                   269,000     315,000     197,000     226,000     256,000     184,000     268,000     254,000     212,000     321,000     293,000     290,000
   65-74                                   233,000     267,000     207,000     219,000     317,000     253,000     201,000     251,000     234,000     321,000     388,000     286,000
   ≥ 75                                    312,000     292,000     212,000     246,000     315,000     202,000     311,000     204,000     198,000     311,000     340,000     221,000
  Total                                    1,532,000   1,549,000   1,299,000   1,292,000   1,555,000   1,147,000   1,488,000   1,316,000   1,297,000   1,588,000   1,763,000   1,468,000

Annual rate per 10,000 US civilian population. COPD includes ICD-9-CM codes 490-492 or 496. See [Table 5](#t05){ref-type="table"} legend for expansion of abbreviation.

Data not available for other specific race groups.

###### 

---Estimated Annual Rate of ED Visits for COPD as the First-Listed Diagnosis Among Adults Aged ≥ 25 Years, by Race, Sex, and Age Group---United States, National Hospital Ambulatory Medical Care Survey, 1999-2010

  Variable                                                                  1999    2000    2001    2002    2003    2004    2005    2006    2007    2008    2009    2010    *P* for Linear Trend
  ------------------------------------------------------------------------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ----------------------
  Race^[a](#tfn14){ref-type="table-fn"},[b](#tfn15){ref-type="table-fn"}^                                                                                                   
   White                                                                    82.7    86.7    69.0    68.4    78.9    61.4    70.6    60.4    66.0    77.8    86.9    70.6    .541
   Black                                                                    160.8   133.0   120.8   120.0   143.4   87.7    166.9   153.2   94.4    121.1   123.4   112.6   .411
  Sex[^a^](#tfn14){ref-type="table-fn"}                                                                                                                                     
   Women                                                                    87.7    96.9    75.0    79.0    91.5    62.5    83.5    71.3    82.1    82.4    97.9    88.0    .769
   Men                                                                      95.2    82.4    70.4    62.4    77.0    62.5    74.3    64.9    49.1    78.4    79.3    54.5    .072
  Age group, y                                                                                                                                                              
   25-44                                                                    54.3    58.6    58.9    50.4    45.2    43.4    60.0    38.2    48.7    44.1    55.0    48.2    .166
   45-54                                                                    75.8    52.5    49.7    46.0    72.5    36.5    51.1    68.2    58.7    62.8    67.1    64.4    .281
   55-64                                                                    116.8   133.5   78.4    85.4    92.4    63.8    88.8    80.9    65.1    95.8    84.7    80.8    .478
   65-74                                                                    130.9   150.3   114.7   121.6   175.4   139.1   109.2   134.7   122.2   161.3   188.6   135.0   .505
   ≥ 75                                                                     212.9   195.2   135.8   154.6   194.9   123.0   185.8   120.4   115.8   179.2   195.5   124.5   .142
  Total[^a^](#tfn14){ref-type="table-fn"}                                   89.8    89.6    72.5    71.2    84.6    61.9    78.8    67.8    66.8    79.5    88.3    72.0    .432
  Total[^c^](#tfn16){ref-type="table-fn"}                                   88.3    88.4    71.9    70.6    84.2    61.3    78.5    68.5    66.9    81.0    89.2    73.6    .428

Annual rate per 10,000 US civilian population. COPD includes ICD-9-CM codes 490-492 or 496. All relative SEs are ≤ 30%. See [Table 5](#t05){ref-type="table"} legend for expansion of abbreviation.

Age-adjusted to the 2000 US standard population aged ≥ 25 y.

Data not available for other specific race groups.

Unadjusted rate.

Hospitalizations (NHDS)
-----------------------

In 2010, there were an estimated 699,000 hospitalizations (unadjusted rate, 34.4 per 10,000 US civilian population; age-adjusted rate, 32.2 per 10,000 US civilian population) for COPD as the first-listed diagnosis among adults aged ≥ 25 years. Age-adjusted rates of hospitalizations for COPD varied little between men and women in 2010 ([Fig 3](#fig03){ref-type="fig"}) or between blacks and whites during 2009 to 2010 ([Fig 4](#fig04){ref-type="fig"}). The annual number of hospitalizations for COPD fluctuated between 1999 and 2010 ([Table 9](#t09){ref-type="table"}). The age-specific hospital rates for COPD increased with advancing age each year ([Fig 5](#fig05){ref-type="fig"}), and there was a decline in age-specific rates during 1999 to 2010 among adults aged 25 to 44 years (*P* = .039), adults aged 55 to 64 years (*P* = .001), adults aged 65 to 74 years (*P* = .005), and adults aged ≥ 75 years (*P* = .018) ([Table 10](#t10){ref-type="table"}). Declining trends for age-adjusted rates for COPD hospitalization during 1999 to 2010 were observed among all adults (*P* = .001), men (*P* \< .001), and women (*P* = .022) ([Table 10](#t10){ref-type="table"}).

###### 

---Estimated Annual Number of Hospitalizations for COPD as the First-Listed Discharge Diagnosis Among Adults Aged ≥ 25 Years, by Race, Sex, and Age Group---United States, National Hospital Discharge Survey, 1999-2010

  Variable                                 1999      2000      2001      2002      2003      2004      2005      2006      2007      2008      2009      2010
  ---------------------------------------- --------- --------- --------- --------- --------- --------- --------- --------- --------- --------- --------- ---------
  Race[^a^](#tfn17){ref-type="table-fn"}                                                                                                                 
   White                                   500,000   441,000   457,000   462,000   460,000   429,000   505,000   452,000   440,000   493,000   573,000   543,000
   Black                                   59,000    47,000    54,000    53,000    49,000    45,000    50,000    55,000    52,000    59,000    62,000    80,000
  Sex                                                                                                                                                    
   Women                                   402,000   350,000   362,000   368,000   369,000   336,000   387,000   344,000   345,000   414,000   416,000   398,000
   Men                                     300,000   297,000   288,000   293,000   304,000   291,000   324,000   312,000   294,000   296,000   312,000   301,000
  Age group, y                                                                                                                                           
   25-44                                   28,000    28,000    21,000    27,000    24,000    19,000    21,000    23,000    25,000    20,000    18,000    17,000
   45-54                                   59,000    64,000    62,000    66,000    70,000    72,000    81,000    72,000    75,000    75,000    86,000    81,000
   55-64                                   134,000   129,000   115,000   132,000   128,000   123,000   145,000   133,000   126,000   138,000   150,000   145,000
   65-74                                   219,000   188,000   190,000   200,000   189,000   173,000   193,000   183,000   179,000   193,000   211,000   205,000
   ≥ 75                                    261,000   239,000   263,000   236,000   263,000   241,000   271,000   245,000   234,000   284,000   262,000   251,000
  Total                                    702,000   647,000   650,000   662,000   673,000   628,000   711,000   657,000   639,000   710,000   728,000   699,000

Numbers for each variable may not add to total because of rounding. COPD includes ICD-9-CM codes 490-492 or 496. See [Table 5](#t05){ref-type="table"} legend for expansion of abbreviation.

Data not available for other specific race groups. Race was not imputed. Percent missing data for race are shown in e-Table 5.

![Age-specific rates (per 10,000 US civilian population) of hospitalizations for COPD as the first-listed discharge diagnosis among adults aged ≥ 25 years, by year---United States, National Hospital Discharge Survey, 1999-2010.](chest_144_1_284_fig05){#fig05}

###### 

---Estimated Annual Rates of Hospitalizations for COPD as the First-Listed Discharge Diagnosis Among Adults Aged ≥ 25 Years, by Race, Sex, and Age Group---United States, National Hospital Discharge Survey, 1999-2010

  Variable                                                                  1999    2000    2001    2002    2003    2004    2005    2006    2007    2008    2009    2010    *P* for Linear Trend
  ------------------------------------------------------------------------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ----------------------
  Race^[a](#tfn18){ref-type="table-fn"},[b](#tfn19){ref-type="table-fn"}^                                                                                                   
   White                                                                    32.7    28.5    28.5    28.6    28.0    25.8    29.8    26.3    25.3    27.6    31.6    29.5    .104
   Black                                                                    37.6    29.2    29.2    30.4    28.5    24.9    26.9    29.9    26.2    28.8    30.2    39.5    .563
  Sex[^a^](#tfn18){ref-type="table-fn"}                                                                                                                                     
   Women                                                                    40.8    35.3    35.3    35.3    34.5    31.1    35.2    30.9    30.4    35.6    35.3    33.4    .022
   Men                                                                      39.9    39.0    39.0    36.7    37.4    35.3    38.4    36.4    33.1    32.9    33.9    31.6    \< .001
  Age group, y                                                                                                                                                              
   25-44                                                                    3.3     3.3     2.4     3.2     2.9     2.3     2.5     2.8     3.0     2.4     2.2     2.1     .039
   45-54                                                                    16.5    17.3    15.9    16.5    17.1    17.2    19.0    16.7    17.1    16.9    19.4    18.4    .102
   55-64                                                                    57.9    54.0    45.5    49.7    45.8    42.3    47.8    42.1    38.6    41.0    43.1    40.2    .001
   65-74                                                                    121.6   104.7   103.6   109.7   103.0   93.9    103.7   96.8    92.7    96.0    101.5   95.5    .005
   ≥ 75                                                                     161.3   144.8   154.7   136.1   149.7   135.0   149.1   133.7   126.2   151.4   139.8   131.4   .018
  Total[^a^](#tfn18){ref-type="table-fn"}                                   40.2    36.6    36.6    35.5    35.5    32.5    36.1    32.8    31.4    34.1    34.3    32.2    .001
  Total[^c^](#tfn20){ref-type="table-fn"}                                   39.7    36.2    35.4    35.5    35.8    33.0    36.8    33.6    32.4    35.6    36.2    34.4    .018

Annual rate per 10,000 US civilian population. COPD includes ICD-9-CM codes 490-492 or 496. All relative SEs are ≤ 30%. See [Table 5](#t05){ref-type="table"} legend for expansion of abbreviation.

Age-adjusted to the 2000 US standard population aged ≥ 25 y.

Data not available for other specific race groups. Race was not imputed. Percent missing data for race are shown in e-Table 5.

Unadjusted rate.

Medicare Hospitalizations (Medicare Part A Hospital Claims)
-----------------------------------------------------------

In 2010, there were 312,654 (unadjusted rate, 11.11 per 1,000 Medicare enrollees aged ≥ 65 years; age-adjusted rate, 11.18 per 1,000 Medicare enrollees aged ≥ 65 years) hospital discharge claims for COPD as the first-listed diagnosis. The annual number of Medicare hospitalizations for COPD fluctuated during 1999 to 2010 ([Table 11](#t11){ref-type="table"}). Age-specific rates for those aged 65 to 74 years declined significantly (*P* = .033) ([Table 12](#t12){ref-type="table"}). Age-adjusted rates were highest among Native American enrollees and lowest among Asian enrollees in most years ([Fig 6](#fig06){ref-type="fig"}). Age-adjusted rates for Medicare hospitalizations for COPD declined during 1999 to 2010 for all enrollees overall (*P* = .045) and men (*P* = .022), but the decline was not significant for women (*P* = .138) or for specific race groups ([Table 12](#t12){ref-type="table"}).

###### 

---Annual Number of Medicare Hospitalizations for COPD as the First-Listed Discharge Diagnosis Among Medicare Beneficiaries Aged ≥ 65 Years, by Race/Ethnicity, Sex, and Age Group---United States, Medicare Part A Hospital Claims, 1999-2010

  Variable               1999      2000      2001      2002      2003      2004      2005      2006      2007      2008      2009      2010
  ---------------------- --------- --------- --------- --------- --------- --------- --------- --------- --------- --------- --------- ---------
  Race/ethnicity                                                                                                                       
   White, non-Hispanic   311,551   282,944   286,225   288,338   280,631   255,896   277,529   266,810   234,796   277,693   265,149   273,918
   Black, non-Hispanic   25,468    23,545    24,280    25,530    24,313    22,003    24,312    22,740    21,344    23,893    24,611    27,106
   Hispanic              4,422     4,030     4,256     4,347     4,183     3,945     4,505     4,196     3,892     4,531     4,517     4,770
   Native American       581       519       577       1,018     1,210     1,229     1,228     1,553     1,176     1,468     1,432     1,547
   Asian                 1,818     1,553     1,683     1,772     1,750     2,865     1,901     1,719     1,879     2,327     2,369     2,442
  Sex                                                                                                                                  
   Women                 194,756   177,658   179,941   181,588   176,902   162,180   174,986   167,743   149,181   174,940   168,625   175,597
   Men                   154,141   139,843   141,875   143,795   139,164   126,169   138,283   132,445   116,711   138,212   132,266   137,057
  Age group, y                                                                                                                         
   65-74                 152,179   136,721   138,118   137,777   136,354   122,701   131,321   125,471   111,455   130,057   128,891   134,072
   ≥ 75                  196,718   180,780   183,698   187,606   179,802   165,648   181,948   174,717   154,437   183,095   172,000   178,582
  Total                  348,897   317,501   321,816   325,383   316,156   288,349   313,269   300,188   265,892   313,152   300891    312,654

COPD includes ICD-9-CM codes 490-492 or 496. See [Table 5](#t05){ref-type="table"} legend for expansion of abbreviation.

###### 

---Annual Rates of Medicare Hospitalizations for COPD Among Medicare Beneficiaries Aged ≥ 65 Years, by Race/Ethnicity, Sex, and Age Group---United States, Medicare Part A Hospital Claims, 1999-2010

  Variable                                  1999    2000    2001    2002    2003    2004    2005    2006    2007    2008    2009    2010    *P* for Linear Trend
  ----------------------------------------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ----------------------
  Race[^a^](#tfn26){ref-type="table-fn"}                                                                                                    
   White, non-Hispanic                      13.47   12.00   11.80   11.58   11.09   10.02   10.86   10.73   9.61    11.50   11.03   11.31   .052
   Black, non-Hispanic                      12.59   11.29   11.19   11.42   10.63   9.48    10.49   10.29   9.98    11.37   11.55   12.39   .831
   Hispanic                                 13.39   10.89   10.68   10.24   9.30    8.12    9.09    8.77    8.14    9.66    9.44    9.73    .081
   Native American                          19.21   14.65   15.62   11.80   13.14   12.73   11.61   14.84   10.88   13.32   12.62   13.23   .394
   Asian                                    8.42    5.50    5.42    5.20    4.75    6.96    4.36    3.92    4.11    4.91    4.81    4.77    .108
  Sex[^a^](#tfn26){ref-type="table-fn"}                                                                                                     
   Women                                    12.41   11.22   11.08   10.90   10.50   9.52    10.28   10.17   9.22    10.97   10.64   10.99   .138
   Men                                      14.81   13.14   12.83   12.53   11.81   10.54   11.47   11.23   9.99    11.91   11.34   11.56   .022
  Age group, y                                                                                                                              
   65-74                                    11.26   10.01   9.81    9.51    9.24    8.19    8.75    8.58    7.70    8.90    8.72    8.88    .033
   ≥ 75                                     15.49   13.98   13.79   13.67   12.87   11.72   12.86   12.69   11.47   13.94   13.24   13.69   .175
  Total[^a^](#tfn26){ref-type="table-fn"}   13.28   11.91   11.71   11.49   10.97   9.88    10.71   10.55   9.50    11.31   10.87   11.18   .045
  Total[^b^](#tfn27){ref-type="table-fn"}   13.31   11.94   11.74   11.53   11.00   9.91    10.74   10.58   9.51    11.29   10.83   11.11   .034

Annual rate per 1,000 Medicare beneficiaries, aged ≥ 65 y, alive, entitled to Medicare Part A, and not in a managed care plan on July 1 of the given year. COPD includes ICD-9-CM codes 490-492 or 496. See [Table 5](#t05){ref-type="table"} legend for expansion of abbreviation.

Age-adjusted to the 2000 US standard population aged ≥ 65 y.

Unadjusted rate.

![Race-specific age-adjusted rates (per 1,000 Medicare enrollees) of Medicare hospitalizations for COPD as the first-listed discharge diagnosis among Medicare enrollees aged ≥ 65 years, by year---United States, Medicare Part A hospital claims, 1999-2010.](chest_144_1_284_fig06){#fig06}

Medicare hospital claims data provide an opportunity to obtain state-specific estimates ([Table 13](#t13){ref-type="table"}). Changes in age-adjusted rates during 1999 to 2010 varied between states ([Table 14](#t14){ref-type="table"}). A comparison of state-specific Medicare hospital rates in 1999 to 2000 to those in 2009 to 2010 ([Fig 7](#fig07){ref-type="fig"}) demonstrates geographic clustering of the 10 states in 1999 to 2000, with the highest hospitalization rates (14.0-26.6 per 1,000 Medicare enrollees) along the Mississippi River and Ohio River valleys. By 2009 to 2010, there was a marked improvement in rates in many of those states. States with the highest age-adjusted Medicare hospitalization rates in 2009 to 2010 in [Figure 7](#fig07){ref-type="fig"} are similar to those states in [Figure 1](#fig01){ref-type="fig"}, with the highest age-adjusted prevalence of COPD in 2011. [Figure 8](#fig08){ref-type="fig"} shows that there were no significant increases in age-adjusted Medicare hospitalization rates in any state during 1999 to 2010 and identifies those states which have experienced no significant change or a significant decline (*P* \< .05) during the past decade.

###### 

---Annual Number of Medicare Hospitalizations for COPD as the First-Listed Discharge Diagnosis Among Medicare Beneficiaries Aged ≥ 65 Years, by State---United States, Medicare Part A Hospital Claims, 1999-2010

  State                  1999      2000      2001      2002      2003      2004      2005      2006      2007      2008      2009      2010
  ---------------------- --------- --------- --------- --------- --------- --------- --------- --------- --------- --------- --------- ---------
  Alabama                8,996     8,172     8,751     8,779     8,442     7,216     7,842     7,098     6,805     8,132     7,686     7,704
  Alaska                 391       404       414       378       387       341       320       408       290       355       335       373
  Arizona                3,317     2,890     2,914     3,152     3,101     3,006     3,638     2,967     2,652     3,543     3,482     4,082
  Arkansas               5,444     5,033     4,991     5,202     4,798     4,148     4,563     4,598     3,651     3,957     3,858     3,956
  California             20,181    17,174    17,142    17,382    17,045    14,601    15,331    14,392    14,367    17,093    17,302    18,743
  Colorado               2,830     2,264     2,332     2,317     2,350     2,013     2,337     2,406     1,954     2,535     2,117     2,397
  Connecticut            3,032     2,964     3,125     3,315     3,276     3,227     3,487     3,359     3,300     3,886     3,698     3,768
  Delaware               983       1,038     992       1,028     1,047     1,088     1,188     1,052     1,069     1,105     1,066     1,257
  District of Columbia   463       458       443       418       391       343       438       363       336       445       404       451
  Florida                23,513    21,200    22,448    23,194    22,096    22,210    22,732    21,121    19,590    23,592    23,926    24,952
  Georgia                9,983     9,269     9,434     9,591     9,089     8,215     9,146     9,092     7,491     8,617     8,660     8,517
  Hawaii                 470       412       421       406       379       377       386       369       373       424       410       424
  Idaho                  1,249     1,001     994       930       852       659       729       884       567       609       616       603
  Illinois               16,794    14,861    15,180    15,556    14,669    13,354    14,618    14,566    13,146    16,660    16,089    16,021
  Indiana                10,357    9,831     9,774     9,551     9,109     8,178     9,334     9,334     7,543     9,624     8,835     8,682
  Iowa                   5,008     4,308     4,234     3,734     3,369     2,977     2,940     3,736     2,424     2,774     2,546     2,645
  Kansas                 3,822     3,321     3,247     3,205     3,282     2,759     3,066     3,542     2,440     2,749     2,450     2,441
  Kentucky               10,655    9,496     9,959     9,839     9,730     8,546     9,544     9,752     7,731     9,423     9,188     8,986
  Louisiana              6,520     6,031     6,373     6,418     6,228     5,258     5,887     5,155     4,490     5,389     5,150     5,287
  Maine                  2,380     2,477     2,056     1,863     1,837     1,635     1,761     1,938     1,438     1,625     1,712     1,588
  Maryland               5,437     5,283     5,631     5,746     5,695     5,211     5,898     6,221     6,223     7,086     6,470     6,522
  Massachusetts          7,890     7,447     7,117     7,053     7,170     6,754     7,277     7,108     6,828     8,437     8,185     8,689
  Michigan               14,207    12,606    12,377    13,285    12,984    12,892    13,915    13,152    11,491    13,053    12,627    14,282
  Minnesota              4,764     4,130     4,291     4,061     3,745     3,560     3,667     3,354     2,513     3,097     2,862     2,930
  Mississippi            6,361     6,017     6,191     6,117     5,851     5,128     5,666     5,090     4,164     4,858     5,005     4,983
  Missouri               8,527     7,535     8,037     7,709     7,455     7,023     7,909     7,254     6,082     7,451     6,884     6,932
  Montana                1,306     1,142     1,203     1,072     1,015     874       867       1,100     704       759       718       717
  Nebraska               2,108     1,713     1,542     1,452     1,443     1,208     1,590     1,981     1,337     1,693     1,516     1,705
  Nevada                 1,969     1,551     1,488     1,576     1,529     1,332     1,544     1,547     1,346     1,754     1,890     2,062
  New Hampshire          1,329     1,450     1,361     1,305     1,335     1,452     1,318     1,640     1,358     1,626     1,541     1,499
  New Jersey             10,193    9,420     9,584     10,325    10,742    10,172    11,049    10,265    9,882     11,328    10,836    11,166
  New Mexico             1,569     1,309     1,342     1,400     1,356     1,138     1,430     1,214     1,116     1,348     1,316     1,418
  New York               20,526    18,680    17,835    17,878    17,360    16,983    18,046    17,177    15,787    17,987    17,643    19,369
  North Carolina         12,146    11,326    11,079    10,940    11,079    9,511     10,610    9,911     8,819     10,097    9,655     9,530
  North Dakota           970       770       742       633       576       548       631       838       553       495       393       410
  Ohio                   18,466    16,823    17,282    17,601    17,255    15,239    16,863    16,229    14,217    16,242    14,712    15,278
  Oklahoma               5,558     5,057     5,456     5,392     5,256     4,779     5,186     5,055     4,973     5,587     5,227     5,574
  Oregon                 2,329     1,925     2,073     2,201     2,029     1,672     1,646     1,768     1,354     1,469     1,544     1,551
  Pennsylvania           19,100    17,406    16,841    17,294    16,401    15,426    16,677    14,169    12,866    14,900    13,724    15,694
  Rhode Island           1,178     1,167     1,063     1,014     1,054     954       1,021     972       969       1,140     1,115     1,288
  South Carolina         5,427     5,104     5,054     5,327     5,277     4,815     5,333     4,689     4,444     5,153     4,910     5,002
  South Dakota           1,219     1,052     938       890       860       649       751       1,104     534       653       668       605
  Tennessee              10,251    9,771     9,989     10,025    10,101    9,285     9,799     9,102     8,215     10,032    9,587     9,188
  Texas                  21,794    20,395    22,665    23,830    23,043    20,590    22,387    20,379    19,180    22,262    21,264    22,557
  Utah                   750       623       718       692       645       521       628       547       425       528       498       551
  Vermont                719       774       632       629       601       618       568       615       458       499       549       548
  Virginia               9,254     8,672     8,793     8,712     8,561     7,331     8,008     7,356     6,865     8,030     7,579     7,306
  Washington             3,660     3,303     3,459     3,403     3,180     2,852     3,516     3,562     2,925     3,516     3,478     3,540
  West Virginia          6,678     6,295     5,889     5,880     5,830     4,979     5,249     5,541     4,474     4,859     4,611     4,706
  Wisconsin              6,064     5,573     5,353     5,143     4,747     4,290     4,441     4,548     3,639     4,088     3,828     3,735
  Wyoming                760       578       567       540       504       412       492       568       494       588       526       440
  Total                  348,897   317,501   321,816   288,338   316,156   288,349   313,269   300,188   265,892   313,152   300,891   312,654

COPD includes ICD-9-CM codes 490-492 or 496. See [Table 5](#t05){ref-type="table"} legend for expansion of abbreviation.

###### 

---Age-Adjusted Annual Rates for Medicare Hospitalizations With COPD as the First-Listed Discharge Diagnosis Among Medicare Beneficiaries Aged ≥ 65 Years, by State---United States, Medicare Part A Hospital Claims, 1999-2010

  State[^a^](#tfn28){ref-type="table-fn"}   1999    2000    2001    2002    2003    2004    2005    2006    2007    2008    2009    2010    *P* for Linear Trend
  ----------------------------------------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ----------------------
  Alabama                                   18.10   16.42   17.33   17.04   16.17   13.84   15.11   13.99   13.56   16.73   16.15   15.68   .121
  Alaska                                    12.62   12.31   12.26   10.89   10.60   9.05    8.01    9.85    6.59    7.76    6.88    7.49    \< .001
  Arizona                                   9.88    7.97    7.61    7.63    7.14    6.64    7.83    6.89    6.05    8.01    7.66    8.62    .541
  Arkansas                                  16.14   14.84   14.70   14.67   13.44   11.53   12.54   13.02   10.70   11.67   11.36   11.53   \< .001
  California                                11.33   9.44    9.06    8.51    7.98    6.71    6.95    6.56    6.49    7.57    7.54    8.04    .027
  Colorado                                  11.93   9.22    8.96    8.35    8.17    6.79    7.71    8.01    6.44    8.27    6.80    7.49    .015
  Connecticut                               8.52    8.21    8.02    7.70    7.56    7.41    8.01    7.81    7.90    9.55    9.30    9.48    .057
  Delaware                                  10.97   11.34   10.48   10.52   10.44   10.61   11.33   9.87    9.89    10.06   9.53    10.79   .060
  District of Columbia                      8.17    8.00    7.60    7.21    6.87    6.11    7.89    6.66    6.22    8.33    7.41    8.08    .736
  Florida                                   13.32   11.69   11.77   11.52   10.65   10.57   10.88   10.58   9.88    12.02   12.15   12.55   .747
  Georgia                                   14.76   13.50   13.29   13.28   12.35   10.70   11.67   11.98   10.00   11.25   11.25   11.63   .004
  Hawaii                                    5.18    4.34    4.50    4.29    3.92    3.80    3.81    3.72    3.70    4.17    4.05    4.22    .078
  Idaho                                     9.87    7.81    7.57    6.93    6.23    4.72    5.13    6.50    4.28    4.65    4.78    4.62    \< .001
  Illinois                                  13.49   11.91   11.91   11.72   10.89   9.88    10.79   10.94   9.95    12.53   11.94   11.71   .439
  Indiana                                   14.92   14.09   13.85   13.38   12.57   11.21   12.73   13.09   10.88   14.05   13.11   12.83   .202
  Iowa                                      12.18   10.46   10.28   9.04    8.16    7.26    7.24    9.54    6.31    7.18    6.65    6.91    \< .001
  Kansas                                    11.95   10.41   10.21   9.91    9.93    8.29    9.21    10.81   7.53    8.54    7.67    7.57    .001
  Kentucky                                  23.83   21.10   21.76   21.07   20.58   17.87   19.67   20.45   16.93   20.80   20.34   19.77   .080
  Louisiana                                 16.95   15.23   15.38   15.02   14.35   12.03   13.93   12.43   11.12   13.62   13.23   13.52   .015
  Maine                                     13.60   14.05   11.48   10.28   10.05   8.83    9.44    10.31   7.65    8.75    9.67    9.03    .005
  Maryland                                  11.52   10.63   10.26   10.35   10.17   9.23    10.36   11.10   11.06   12.40   10.91   10.80   .338
  Massachusetts                             13.15   12.28   11.53   11.28   10.85   10.14   10.95   10.66   10.31   12.72   12.30   12.93   .908
  Michigan                                  12.71   11.24   11.00   11.32   10.93   10.74   11.53   11.24   10.99   13.38   13.43   13.05   .139
  Minnesota                                 9.83    8.41    8.60    8.08    7.42    7.08    7.46    7.62    5.97    7.69    7.37    8.10    .036
  Mississippi                               19.86   18.74   19.27   18.73   17.72   15.34   16.89   16.06   13.05   15.16   15.51   15.19   \< .001
  Missouri                                  13.92   12.41   13.12   12.53   11.82   11.05   12.40   11.52   9.76    12.06   11.24   11.31   .014
  Montana                                   11.44   9.73    10.13   8.95    8.36    7.10    6.98    9.27    6.10    6.63    6.34    6.26    \< .001
  Nebraska                                  9.92    7.90    7.11    6.66    6.64    5.54    7.32    9.32    6.38    8.14    7.26    8.09    .882
  Nevada                                    15.60   11.66   10.85   10.78   9.79    8.31    9.31    9.20    7.83    9.83    10.37   10.85   .177
  New Hampshire                             10.37   10.12   9.35    8.84    8.83    9.41    8.40    10.25   8.42    10.01   9.48    9.08    .504
  New Jersey                                11.69   10.45   10.42   10.73   11.02   10.40   11.34   10.56   10.11   11.55   11.13   11.36   .576
  New Mexico                                10.62   8.60    8.26    8.52    8.10    6.73    8.29    7.24    6.59    7.89    7.68    8.09    .071
  New York                                  11.64   10.52   9.94    9.92    9.64    9.09    9.79    9.62    9.05    10.52   10.46   11.56   .933
  North Carolina                            13.92   12.78   12.33   12.02   11.91   10.11   11.22   10.76   9.75    11.07   10.49   10.08   \< .001
  North Dakota                              10.51   8.34    8.04    6.91    6.27    5.98    6.88    9.44    6.31    5.72    4.53    4.71    .003
  Ohio                                      15.65   14.13   14.11   14.24   13.77   12.06   13.36   13.13   11.71   14.78   13.59   15.60   .494
  Oklahoma                                  14.40   13.13   14.07   13.60   13.09   11.83   12.79   12.95   12.46   14.01   13.03   13.77   .524
  Oregon                                    9.23    7.52    7.83    8.11    7.33    5.89    5.72    6.38    4.99    5.34    5.67    5.52    \< .001
  Pennsylvania                              14.25   13.18   12.16   12.41   11.86   11.21   12.28   11.15   10.46   12.82   12.00   13.65   .289
  Rhode Island                              12.72   12.46   11.56   10.93   11.66   10.60   11.63   11.13   11.26   13.29   13.03   14.62   .223
  South Carolina                            12.28   11.30   10.98   11.38   11.06   9.88    10.73   9.62    9.24    10.73   10.11   10.04   .008
  South Dakota                              11.49   9.86    8.81    8.39    7.92    5.94    6.84    10.06   5.04    6.28    6.19    5.55    .004
  Tennessee                                 16.34   15.49   15.54   15.68   15.75   14.43   15.28   14.82   13.66   16.73   15.82   15.12   .442
  Texas                                     13.94   12.81   13.11   13.11   12.29   10.82   11.68   10.79   10.23   11.87   11.23   11.69   .009
  Utah                                      4.44    3.60    4.07    3.85    3.50    2.76    3.31    3.22    2.61    3.37    3.29    3.62    .073
  Vermont                                   9.92    10.33   8.37    8.24    7.79    7.89    7.18    7.62    5.65    6.08    6.61    6.48    \< .001
  Virginia                                  13.44   12.15   11.90   11.62   11.20   9.44    10.13   9.54    8.98    10.47   9.82    9.27    \< .001
  Washington                                8.19    7.13    6.96    6.51    5.93    5.14    6.19    6.26    5.16    6.20    6.13    6.09    .065
  West Virginia                             27.38   25.81   24.10   23.95   23.62   20.11   21.06   22.62   21.20   23.50   22.52   22.50   .033
  Wisconsin                                 9.32    8.56    8.16    7.60    7.04    6.43    6.84    7.54    6.35    7.41    7.20    7.12    .022
  Wyoming                                   14.19   10.65   10.22   9.67    8.83    7.12    8.31    9.66    8.28    9.72    8.58    7.02    .023
  Total[^a^](#tfn28){ref-type="table-fn"}   13.28   11.91   11.71   11.49   10.97   9.88    10.71   10.55   9.50    11.31   10.87   11.18   .045

Annual rate per 1,000 Medicare enrollees aged ≥ 65 y, alive, entitled to Medicare Part A, and not in a managed care plan on July 1 of the given year. COPD includes ICD-9-CM codes 490-492 or 496. See [Table 5](#t05){ref-type="table"} legend for expansion of abbreviation.

Age-adjusted to the 2000 US standard population aged ≥ 65 y.

![Age-adjusted rates (per 1,000 Medicare enrollees) of Medicare hospitalizations for COPD as the first-listed discharge diagnosis among Medicare enrollees aged ≥ 65 years---United States, Medicare Part A hospital claims, 1999-2000 and 2009-2010.](chest_144_1_284_fig07){#fig07}

![Significant linear change (*P* \< .05) in state-specific age-adjusted rates (per 1,000 Medicare enrollees) of Medicare hospitalizations for COPD as the first-listed discharge diagnosis among Medicare enrollees aged ≥ 65 years---United States, Medicare Part A hospital claims, 1999-2010.](chest_144_1_284_fig08){#fig08}

Deaths (Death Certificates)
---------------------------

In 2010, there were 133,575 deaths (crude rate, 65.5 per 100,000 US population; age-adjusted rate, 63.1 per 100,000 population) among adults aged ≥ 25 years. Although the annual number of deaths increased somewhat during 1999 to 2010 ([Table 15](#t15){ref-type="table"}), the age-adjusted death rate for COPD declined during 1999 to 2010 among men (*P* = .001) but did not change significantly in women (*P* = .127) or overall (*P* = .163) ([Table 16](#t16){ref-type="table"}). Age-specific rates increased among adults aged 45 to 54 years (*P* \< .001) but declined among those aged 55 to 64 years (*P* = .002) and 65 to 74 years (*P* \< .001). The age-specific rates each year were highest among those aged ≥ 75 years and 65 to 74 years ([Fig 9](#fig09){ref-type="fig"}). Age-adjusted rates were highest among non-Hispanic whites followed by American Indian/Alaska Natives, non-Hispanic blacks, Hispanics, and Asian/Pacific Islanders ([Fig 10](#fig10){ref-type="fig"}). During 1999 to 2010, age-adjusted rates increased among American Indian/Alaska Natives (*P* = .008) and declined among Hispanics (*P* = .038) and Asian/Pacific Islanders (*P* \< .001) but did not change significantly among non-Hispanic whites or non-Hispanic blacks.

###### 

---Annual Number of Adults Aged ≥ 25 Years With COPD as the Underlying Cause of Death, by Race, Sex, and Age Group---United States, Mortality Component of the National Vital Statistics System, 1999-2010

  Variable                                           1999      2000      2001      2002      2003      2004      2005      2006      2007      2008      2009      2010
  -------------------------------------------------- --------- --------- --------- --------- --------- --------- --------- --------- --------- --------- --------- ---------
  Race/ethnicity[^a^](#tfn30){ref-type="table-fn"}                                                                                                                 
   White, non-Hispanic                               107,706   106,198   107,145   108,481   110,088   106,393   113,939   108,435   111,477   123,171   119,715   119,894
   Black, non-Hispanic                               6,640     6,327     6,355     6,585     6,565     6,274     7,086     6,660     6,896     7,743     7,489     7,700
   Hispanic                                          2,488     2,341     2,512     2,724     2,827     2,779     3,166     2,994     3,238     3,623     3,672     3,817
   AIAN                                              360       381       378       413       455       457       467       468       559       579       555       643
   API                                               923       925       985       969       1,037     1,013     1,136     1,144     1,146     1,288     1,265     1,265
  Sex                                                                                                                                                              
   Women                                             58,040    58,436    59,789    60,673    62,363    60,194    65,193    62,290    63,813    71,031    69,334    69,797
   Men                                               60,416    58,058    57,908    58,807    58,904    56,940    60,812    57,633    59,678    65,606    63,583    63,778
  Age group, y                                                                                                                                                     
   25-44                                             494       500       554       586       573       554       558       519       521       566       506       453
   45-54                                             2,472     2,618     2,695     2,842     2,883     2,920     3,356     3,326     3,596     3869      4,083     3,861
   55-64                                             10,643    10,130    10,545    10,670    11,451    11,183    12,173    11,823    12,273    13518     13,636    13,674
   65-74                                             31,699    30,249    29,942    29,040    29,241    27,740    29,296    27,640    28,100    31390     30,762    31,254
   ≥ 75                                              73,148    72,997    73,961    76,342    77,119    74,737    80,622    76,615    79,001    87,294    83,930    84,333
  Total                                              118,456   116,494   117,697   119,480   121,267   117,134   126,005   119,923   123,491   136,637   132,917   133,575

COPD includes ICD-10 codes J40--J44 from the WHO. AIAN = non-Hispanic American Indian/Alaska Natives; API = non-Hispanic Asian/Pacific Islanders; ICD-10 = International Classification of Diseases, tenth revision; WHO = World Health Organization.

A summation of the annual numbers will not equal the total annual number because of small numbers of death in other race/ethnicity or unknown categories.

###### 

---Annual Rates for Deaths With COPD as the Underlying Cause Of Death Among Adults Aged ≥ 25 Years, by Race, Sex, and Age Group---United States, Mortality Component of the National Vital Statistics System, 1999-2010

  Variable                                           1999    2000    2001    2002    2003    2004    2005    2006    2007    2008    2009    2010    *P* for Linear Trend
  -------------------------------------------------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ----------------------
  Race/ethnicity[^a^](#tfn32){ref-type="table-fn"}                                                                                                   
   White, non-Hispanic                               72.0    70.5    70.4    70.5    70.7    67.7    71.5    67.2    68.1    74.1    71.0    70.2    .870
   Black, non-Hispanic                               45.9    43.0    42.6    43.6    42.5    39.8    43.8    40.3    40.8    44.6    41.7    41.8    .240
   Hispanic                                          32.9    29.7    29.7    30.8    30.5    28.2    30.4    27.4    28.1    29.8    28.8    28.5    .038
   AIAN                                              54.2    53.0    51.6    54.1    57.3    55.0    54.7    53.2    60.8    59.3    56.1    62.9    .008
   API                                               25.7    24.8    24.2    22.2    22.7    21.2    22.1    21.0    19.8    21.0    19.7    19.0    \< .001
  Sex^d^                                                                                                                                             
   Women                                             54.6    54.4    54.9    55.0    55.9    53.3    56.8    53.6    54.0    59.1    56.8    56.3    .127
   Men                                               88.2    83.8    81.8    81.7    79.9    75.7    78.8    73.0    73.7    79.2    74.8    73.6    .001
  Age group, y                                                                                                                                       
   25-44                                             0.6     0.6     0.7     0.7     0.7     0.7     0.7     0.6     0.6     0.7     0.6     0.6     ...
   45-54                                             6.8     6.9     6.8     7.1     7.1     7.0     7.9     7.7     8.2     8.7     9.1     8.6     \< .001
   55-64                                             44.8    41.7    42.0    40.0    40.9    38.2    39.7    37.0    37.0    39.6    38.5    37.5    .002
   65-74                                             172.1   164.5   162.9   157.9   158.1   148.6   155.2   143.9   142.6   153.1   144.9   143.9   \< .001
   ≥ 75                                              446.6   439.7   437.5   445.6   444.2   426.2   453.7   426.6   435.8   477.7   456.4   454.5   .212
  Total[^a^](#tfn32){ref-type="table-fn"}            67.0    65.2    64.9    65.0    64.9    61.8    65.3    61.1    61.7    66.9    63.8    63.1    .163
  Total[^b^](#tfn33){ref-type="table-fn"}            65.7    64.0    63.9    64.2    64.5    61.6    65.4    61.5    62.6    68.4    65.8    65.5    .515

Annual rate per 100,000 US population. COPD includes ICD-10 codes J40--J44 from the WHO. Death rates for 2001-2009 will differ from previous reports because 2001-2009 population denominators have been revised In CDC Wonder (Oct 2012). See [Table 15](#t15){ref-type="table"} legend for expansion of abbreviations.

Age-adjusted to the 2000 US standard population aged ≥ 25 y.

Unadjusted rate.

![Age-specific death rates (per 100,000) for COPD as the underlying cause of death among adults aged ≥ 25 years, by year---United States, Mortality Component of the National Vital Statistics System, 1999-2010.](chest_144_1_284_fig09){#fig09}

![Race-specific age-adjusted death rates (per 100,000) for COPD as the underlying cause of death among adults aged ≥ 25 years, by year---United States, Mortality Component of the National Vital Statistics System, 1999-2010.](chest_144_1_284_fig10){#fig10}

Numbers of deaths ([Table 17](#t17){ref-type="table"}) and age-adjusted death rates varied during 1999 to 2010 in most states ([Table 18](#t18){ref-type="table"}). [Figure 11](#fig11){ref-type="fig"} compares aggregated age-adjusted state-specific death rates for COPD in 1999 to 2000 to those for 2009 to 2010. In 1999 to 2000, states with the highest death rates (75.0-103.9 per 100,000) were along the Ohio River valley and in multiple western states. Geographic clustering of COPD death rates aggregated for 2009 to 2010 was observed in states along the Ohio River Valley and in several western states and also in several southern states ([Fig 11](#fig11){ref-type="fig"}). Although death rates for COPD declined in many states during 1999 to 2010, five states (Alabama, Mississippi, Arkansas, Oklahoma, and South Dakota) experienced significant increases in deaths from COPD ([Fig 12](#fig12){ref-type="fig"}).

###### 

---Annual Number of Adults Aged ≥ 25 Years With COPD as the Underlying Cause of Death, by State---United States, Mortality Component of the National Vital Statistics System, 1999-2010

  State                  1999      2000      2001      2002      2003      2004      2005      2006      2007      2008      2009      2010
  ---------------------- --------- --------- --------- --------- --------- --------- --------- --------- --------- --------- --------- ---------
  Alabama                2,095     1,964     2,125     2,245     2,347     2,256     2,318     2,239     2,463     2,655     2,693     2,784
  Alaska                 133       125       134       132       132       128       145       129       164       176       187       165
  Arizona                2,414     2,410     2,382     2,462     2,448     2,328     2,723     2,695     2,605     2,860     2,773     2,836
  Arkansas               1,296     1,328     1,297     1,383     1,439     1,375     1,508     1437      1,587     1,833     1,772     1,732
  California             12,488    12,092    12,356    12,088    12,833    11,971    12,608    12,223    11,995    12,870    12,393    12,455
  Colorado               1,791     1,715     1,762     1,773     1,864     1,823     1,864     1,873     1,948     2,128     2,012     2,143
  Connecticut            1,366     1,469     1,429     1,385     1,395     1,375     1,421     1,400     1,310     1,461     1,389     1,237
  Delaware               316       322       286       335       333       334       398       338       370       460       421       427
  District of Columbia   150       160       138       125       126       144       123       114       122       133       127       139
  Florida                8,815     8,345     8,621     8,738     8,778     8,703     9,173     8,668     9,092     9,957     9,891     10,076
  Georgia                2,903     2,914     2,950     3,032     3,105     2,980     3,262     3,241     3,269     3,426     3,615     3,694
  Hawaii                 250       233       243       234       249       270       260       258       260       266       269       265
  Idaho                  542       549       562       574       575       544       691       624       639       682       699       701
  Illinois               4,851     4,486     4,499     4,539     4,601     4,493     4,817     4,521     4,552     5,384     5,093     4,998
  Indiana                2,915     2,948     3,053     3,032     3,167     3,030     3,365     3,193     3,130     3,768     3,649     3,697
  Iowa                   1,574     1,454     1,482     1,521     1,620     1,492     1,650     1,603     1,605     1,803     1,777     1,633
  Kansas                 1,323     1,351     1,393     1,328     1,407     1,272     1,529     1,447     1,437     1,581     1,537     1,532
  Kentucky               2,260     2,090     2,204     2,339     2,327     2,202     2,507     2,331     2,577     2,874     2,791     2,721
  Louisiana              1,525     1,591     1,684     1,598     1,660     1,547     1,830     1,630     1,633     1,831     1,826     1,895
  Maine                  730       755       773       769       762       744       813       763       717       774       801       788
  Maryland               1,836     1,828     1,813     1,838     1,887     1,808     1,823     1,761     1,813     1,916     1,980     1,955
  Massachusetts          2,729     2,799     2,699     2,630     2,668     2,466     2,529     2,457     2,260     2,510     2,481     2,306
  Michigan               4,130     4,150     3,974     4,251     4,316     4,099     4,304     4,334     4,466     5,050     4,814     4,943
  Minnesota              1,880     1,794     1,816     1,864     1,742     1,762     1,883     1,706     1,686     2,023     1,879     1,923
  Mississippi            1,217     1,189     1,275     1,320     1,352     1,295     1,416     1,324     1,363     1,464     1,505     1,602
  Missouri               2,949     2,692     2,781     2,765     2,836     2,628     3,002     2,922     2,990     3,663     3,354     3,453
  Montana                538       499       559       554       568       563       569       561       595       681       588       586
  Nebraska               893       794       831       885       851       774       897       845       882       1,009     945       976
  Nevada                 987       959       1,108     1,149     1,155     1,097     1,209     1,046     1,027     1,233     1,215     1,155
  New Hampshire          578       560       596       553       509       581       611       589       593       676       640       594
  New Jersey             2,993     2,874     2,761     2,737     2,775     2,895     3,009     2,732     2,881     3,159     3,010     2,998
  New Mexico             810       725       734       815       893       722       824       857       852       973       955       996
  New York               6,653     6,419     6,514     6,581     6,336     6,430     6,472     6,047     6,281     6,619     6,440     6,509
  North Carolina         3,412     3,533     3,343     3,531     3,725     3,474     4,005     3,858     4,071     4,413     4,196     4,357
  North Dakota           256       280       298       306       284       260       260       274       255       341       330       341
  Ohio                   5,656     5,773     5,686     5,840     5,739     5,727     6,406     5,871     6,263     6,771     6,479     6,520
  Oklahoma               1,683     1,906     1,853     1,920     2,093     1,923     2,296     2,133     2,333     2,645     2,539     2,679
  Oregon                 1,664     1,599     1,646     1,754     1,738     1,711     1,767     1,730     1,816     1,868     1,847     1,888
  Pennsylvania           5,922     5,837     5,646     5,797     5,816     5,774     5,935     5,420     5,871     6,531     6,254     6,025
  Rhode Island           478       493       494       509       474       447       502       467       406       462       500       498
  South Carolina         1,675     1,645     1,640     1,805     1,819     1,699     1,879     1,854     1,949     2,176     2,245     2,175
  South Dakota           315       364       335       364       365       375       424       363       437       474       431       430
  Tennessee              2,655     2,765     2,826     2,874     2,939     2,885     3,076     2,875     3,064     3,462     3,408     3,460
  Texas                  7,139     6,960     7,404     7,400     7,264     7,110     7,666     7,334     7,814     8,605     8,365     8,667
  Utah                   523       482       483       555       525       549       559       548       589       604       547       637
  Vermont                288       295       298       267       295       286       370       308       307       330       353       322
  Virginia               2,549     2,667     2,607     2,620     2,840     2,607     2,770     2,592     2,656     2,899     2,901     2,865
  Washington             2,604     2,533     2,520     2,604     2,545     2,448     2,591     2,553     2,597     2,832     2,835     2,634
  West Virginia          1,208     1,300     1,242     1,195     1,257     1,207     1,315     1,233     1,289     1,567     1,462     1,455
  Wisconsin              2,172     2,202     2,286     2,246     2,223     2,220     2,352     2,273     2,325     2,455     2,397     2,384
  Wyoming                327       277       256       319       270       301       279       329       285       304       307       324
  Total                  118,456   116,494   117,697   119,480   121,267   117,134   126,005   119,923   123,491   136,637   132,917   133,575

COPD includes ICD-10 Codes J40--J44 from the WHO. See [Table 15](#t15){ref-type="table"} legend for expansion of abbreviations.

###### 

---Age-Adjusted Annual Rates for Deaths With COPD as the Underlying Cause of Death Among Adults Aged ≥ 25 Years, by State---United States, Mortality Component of the National Vital Statistics System, 1999-2010

  State[^a^](#tfn36){ref-type="table-fn"}   1999    2000   2001   2002    2003   2004   2005   2006   2007   2008    2009   2010    *P* for Linear Trend
  ----------------------------------------- ------- ------ ------ ------- ------ ------ ------ ------ ------ ------- ------ ------- ----------------------
  Alabama                                   72.2    67.1   72.0   75.5    78.1   74.2   75.4   71.3   77.2   81.4    81.5   83.2    .002
  Alaska                                    81.1    71.0   74.3   69.2    67.0   57.7   62.3   55.2   67.6   67.2    73.6   60.6    .202
  Arizona                                   74.9    73.2   70.3   71.4    68.9   63.8   71.6   68.5   64.4   68.5    64.5   64.5    .003
  Arkansas                                  68.9    70.0   68.0   72.0    74.3   70.3   76.3   71.2   77.8   88.1    83.9   80.8    .001
  California                                68.9    65.6   65.5   63.0    65.4   60.2   61.9   59.2   56.8   59.3    55.7   54.9    \< .001
  Colorado                                  85.4    80.4   80.3   78.9    80.8   77.0   76.8   74.1   74.4   79.1    71.8   75.0    .002
  Connecticut                               55.5    59.3   56.7   54.3    53.8   52.5   53.7   51.9   48.3   53.0    49.6   43.6    \< .001
  Delaware                                  63.8    64.3   55.4   64.0    61.6   60.4   70.0   57.5   61.0   73.5    65.9   65.8    .236
  District of Columbia                      41.7    44.2   38.3   34.5    35.1   40.3   34.7   32.4   34.2   37.4    35.2   37.7    .099
  Florida                                   64.0    60.0   61.1   60.7    60.1   58.4   60.3   56.3   57.8   61.9    60.3   60.3    .338
  Georgia                                   72.5    72.0   71.4   71.6    72.3   67.7   71.9   68.8   67.7   68.1    70.1   70.0    .030
  Hawaii                                    31.9    29.0   29.4   27.4    28.4   29.9   27.7   27.1   26.7   27.0    26.1   24.8    \< .001
  Idaho                                     73.1    72.9   72.7   72.7    70.9   65.6   80.6   70.4   69.9   72.4    71.8   70.1    .597
  Illinois                                  63.0    57.9   57.6   57.6    57.9   56.1   59.4   55.3   55.0   64.2    59.9   58.2    .908
  Indiana                                   76.2    76.6   78.4   77.0    79.2   75.1   82.1   76.6   73.9   87.2    83.6   83.3    .060
  Iowa                                      69.3    63.6   64.2   66.0    69.6   63.6   70.3   67.6   66.4   74.3    73.0   66.2    .157
  Kansas                                    71.8    72.6   74.7   70.8    74.6   67.1   79.4   74.4   73.1   79.4    76.0   75.0    .155
  Kentucky                                  88.6    81.5   85.2   89.4    87.9   82.3   91.6   83.3   90.7   99.0    94.1   90.7    .050
  Louisiana                                 59.0    61.0   63.9   60.1    61.4   56.9   66.3   61.0   60.1   65.8    64.1   65.9    .072
  Maine                                     79.0    80.5   81.1   79.5    77.2   74.5   80.5   73.9   67.7   72.0    73.3   71.3    .002
  Maryland                                  61.0    60.1   58.2   57.9    58.2   54.8   54.0   51.3   52.0   53.5    53.8   52.0    \< .001
  Massachusetts                             61.3    62.3   59.6   57.6    58.0   53.2   54.0   52.1   47.4   51.8    50.6   46.5    \< .001
  Michigan                                  67.0    66.8   63.1   66.5    66.5   62.3   64.6   64.1   64.8   72.0    67.4   68.6    .271
  Minnesota                                 60.2    56.9   57.1   57.4    52.8   52.9   55.6   49.6   48.3   56.5    51.6   51.9    .015
  Mississippi                               70.1    68.1   72.6   74.7    76.1   71.8   77.4   71.9   73.0   76.7    78.7   82.3    .004
  Missouri                                  76.7    69.7   71.2   70.2    71.4   65.5   74.0   70.9   71.3   86.3    77.8   78.8    .097
  Montana                                   87.3    80.0   87.9   85.9    86.9   84.1   83.1   79.9   83.2   92.9    78.5   77.2    .218
  Nebraska                                  73.8    66.1   67.8   71.8    69.2   62.0   71.3   66.0   68.2   76.9    71.5   73.1    .389
  Nevada                                    96.5    92.1   99.2   100.0   95.9   86.7   92.2   76.5   74.0   85.7    80.6   74.9    .001
  New Hampshire                             77.0    73.6   77.0   70.3    63.4   69.9   72.3   67.7   66.4   74.2    69.2   62.9    .053
  New Jersey                                53.0    50.4   47.9   46.9    47.1   48.7   50.1   44.9   46.7   50.4    47.3   46.8    .186
  New Mexico                                78.2    68.6   67.3   73.1    78.8   62.2   68.8   69.4   67.3   74.7    70.7   71.8    .816
  New York                                  53.6    51.0   51.1   50.9    48.5   48.8   48.6   45.1   46.3   48.1    46.4   46.2    \< .001
  North Carolina                            70.6    72.3   67.1   69.3    71.5   65.1   73.4   68.0   69.8   73.5    68.0   69.1    .897
  North Dakota                              51.9    56.6   59.1   61.4    56.5   51.1   50.8   51.7   48.7   64.3    62.2   63.8    .383
  Ohio                                      74.4    75.5   73.7   74.8    72.6   71.8   79.4   71.8   75.5   80.5    75.9   75.7    .291
  Oklahoma                                  73.2    82.2   79.5   81.7    88.4   80.7   95.3   86.6   93.8   104.4   98.3   102.6   \< .001
  Oregon                                    73.5    70.0   70.7   73.8    71.7   69.5   70.0   66.8   68.4   68.9    66.6   67.1    .001
  Pennsylvania                              61.1    59.7   57.4   58.5    58.1   57.6   58.5   52.9   56.7   62.4    59.4   56.8    .463
  Rhode Island                              60.5    61.5   61.7   62.6    57.5   54.2   60.2   56.8   48.4   55.8    60.2   58.4    .147
  South Carolina                            69.5    67.4   65.7   71.2    69.7   63.7   68.6   65.2   66.5   72.0    72.2   68.6    .478
  South Dakota                              55.9    64.0   59.5   63.6    63.7   63.5   71.5   59.8   70.9   75.5    68.0   67.8    .012
  Tennessee                                 74.6    77.1   77.6   77.8    78.3   75.7   79.0   71.7   74.8   82.6    79.5   79.3    .298
  Texas                                     69.0    66.3   69.2   68.0    65.2   62.5   65.6   60.8   63.1   67.8    63.8   64.8    .105
  Utah                                      54.4    49.4   48.2   54.3    50.1   50.8   50.3   47.3   49.0   48.9    43.1   48.8    .031
  Vermont                                   73.2    73.9   73.3   64.4    70.0   67.1   85.7   69.2   67.5   71.2    74.0   67.3    .729
  Virginia                                  64.2    66.2   63.5   62.3    66.5   59.8   61.9   56.5   56.8   60.3    59.0   56.9    .002
  Washington                                76.2    73.1   71.2   72.1    69.2   65.1   67.4   64.6   64.1   68.1    66.4   60.3    \< .001
  West Virginia                             87.4    93.8   89.3   85.1    88.5   84.6   91.1   84.6   87.0   104.9   96.8   95.1    .138
  Wisconsin                                 59.8    60.3   61.8   59.8    58.5   57.8   60.4   57.5   57.8   59.7    58.0   56.5    .019
  Wyoming                                   113.4   94.6   85.1   104.6   86.7   94.8   85.4   99.4   84.6   88.4    87.8   89.6    .119
  Total[^a^](#tfn36){ref-type="table-fn"}   67.0    65.2   64.9   65.0    64.9   61.8   65.3   61.1   61.7   66.9    63.8   63.1    .163

Annual rate per 100,000 US population. COPD includes ICD-10 codes J40--J44 from the WHO. Death rates for 2001-2009 will differ from previous reports because 2001-2009 population denominators have been revised in CDC Wonder (Oct 2012). See [Table 15](#t15){ref-type="table"} legend for expansion of abbreviations.

Age-adjusted to the 2000 US population aged ≥ 25 y.

![Age-adjusted state-specific death rates (per 100,000) for COPD as the underlying cause of death among adults aged ≥ 25 years, by state---United States, Mortality Component of the National Vital Statistics System, 1999-2000 and 2009-2010.](chest_144_1_284_fig11){#fig11}

![Significant linear change (*P* \< .05) in state-specific age-adjusted death rates for COPD as the underlying cause of death among adults aged ≥ 25 years, by state---United States, Mortality Component of the National Vital Statistics System, 1999-2010.](chest_144_1_284_fig12){#fig12}

Discussion
==========

The previous COPD surveillance report noted that rates of hospitalizations and mortality for COPD had increased from 1980 to 2000.^[@r13]^ However, the mortality rate in men and some age groups and hospitalization rates in both men and women have declined since 1999. Rates of physician-based office visits and ED visits for COPD from 1999 to 2010 demonstrated substantial interyear variability and showed no particular trend; however, it is encouraging that there were no increases in office visit rates or ED rates for COPD.

Because smoking is the most important etiologic driver of COPD,^[@r22]^ trends in the prevalence of smoking impacted many of the metrics examined in this surveillance report, although the exact temporal relationship between changes in the smoking prevalence and changes in health-care use and mortality for COPD are not well defined. Since 1965, the prevalence of smoking has decreased considerably. In 1965, 42.4% (unadjusted percentage) of adults aged ≥ 18 years were current smokers compared with 19.3% in 2010.^[@r23]^ The crude prevalence of smoking in 2010 was one-half that in 1965 for both men (21.5% vs 51.9%, respectively) and women (17.3% vs 33.9%, respectively). In 1999 to 2001, American Indian/Alaska Native adults had a higher age-adjusted prevalence of current smoking (30.3% in men and 34.7% in women) compared with white adults (25.1% in men and 22.2% in women),^[@r23]^ which may explain the increase in COPD mortality during 1999 to 2010 in that population. The prevalence of current smoking among American Indian/Alaska Native adults has since declined to 25.1% in men and 21.0% in women for 2008 to 2010^[@r23]^; therefore, a decline in mortality from COPD may be expected for that population in the future. However, a recent report observed that almost 39% of 15 million adults with self-reported COPD in 2011 in the United States continued to smoke.^[@r12]^ This large population represents an important opportunity for physician counseling and referral to smoking cessation interventions such as 1-800-QUIT-NOW.

Two broad currents influence mortality rates estimated from death certificate data: changes in the prevalence of COPD and changes in the case-fatality rate among people with COPD. Although the estimates of the prevalence of self-reported COPD from the NHIS suggest that the prevalence may have declined since 1999, the rates since 2002 have remained fairly stable. A number of treatment strategies have been shown to have the potential to reduce mortality in patients with COPD and include newer medications and evolving guidelines to treat COPD, oxygen therapy, respiratory management, pulmonary rehabilitation, and influenza vaccinations.^[@r24],[@r25]^ The lag times between changes in the prevalence of COPD and the uptake of treatments and COPD mortality rates may differ. The balance of these temporal changes is likely to have a substantial impact on the trajectory of the mortality rate. With continued declines in the smoking prevalence and improved management of patients with COPD, mortality rates can be expected to decline in future years.

The generally small reduction in the age-adjusted mortality rate was limited to men. It is unclear why the mortality rate in women did not fall as well, given the decline in smoking prevalence in women since 1965. If the estimates are valid, these results suggest that research will be needed to address possible explanations for the poor progress among women. These data are consistent with the results of a study showing that the mortality rate among women with an obstructive impairment changed little in contrast to the mortality rate among men with an obstructive impairment.^[@r26]^

The use of spirometry is critical to establishing the diagnosis and severity of COPD. Additional tests that can help in the diagnosis include lung diffusion capacity test, chest radiograph, and arterial blood gas test. GOLD (Global Initiative for Chronic Obstructive Lung Disease) established four levels of COPD on the basis of spirometric measurements: mild, moderate, severe, and very severe.^[@r27]^ The results reported here should be considered in the context of several limitations. Depending on the spirometric criteria used, estimates of prevalence of COPD based on spirometry tests may be as much as double the estimates derived from self-reported information.^[@r13],[@r28],[@r29]^ Consequently, the estimates of self-reported prevalence of COPD in the current surveillance report almost certainly underestimate the true prevalence of this condition. Furthermore, not accounting for the undiagnosed percentage of adults with COPD can also potentially distort demographic comparisons. As shown in the previous surveillance report, men had a higher prevalence than women when the presence of COPD was based on spirometric criteria.^[@r13]^ When self-reported data were used to estimate the prevalence of COPD, however, women had a higher prevalence than men, as was also observed in the present report.

If COPD is underdiagnosed, then the mortality rates presented in the present report likely underestimate the true mortality rates from COPD.^[@r30]‐[@r32]^ Another factor that may contribute to underestimating COPD mortality rates is the possibility that comorbidities may displace COPD as the underlying cause of death that is reported on the death certificate.^[@r33]^ Assuming that underestimates of the COPD mortality rates were approximately constant during the study period, the interpretation of the direction of the trends is valid.

Race was self-reported by participants of the BRFSS and NHIS but was recorded by medical or other personnel in the other data systems. The comparability of race designations among surveys is unknown. For some data systems, such as the NAMCS, NHAMCS, and NHDS, race was missing for a large proportion of records. For example, 16% of the NHDS discharges for 2010 and 23% of NAMCS records in 2010 lacked information about the racial status of the patient. Medicare and death certificate data represented the only data that allowed trend analyses for American Indian/Alaska Natives, Hispanics, and Asian populations. Because race and ethnicity designations are subject to misclassification,^[@r34]^ caution is urged in interpreting racial- and ethnic-specific disparities. In the future, the BRFSS, with its large annual sample size of almost one-half million respondents, will allow trend analyses of prevalence of self-reported COPD among those racial/ethnic groups.

Since 1997, GOLD has striven to increase awareness of COPD as a major public health problem across the globe, to spur efforts to prevent this disease, and to develop guidelines to improve the diagnosis and treatment of COPD. In 2013, it released updated versions of Global Strategy for Diagnosis, Management, and Prevention of COPD.^[@r24]^ Several studies have reported imperfect implementation of the GOLD guidelines in clinical practice.^[@r35]^ Additional efforts may be needed to educate physicians about the management of this condition.

Healthy People objectives provide science-based, 10-year national objectives for improving the health of all Americans; identify nationwide health improvement priorities; and strive to engage multiple sectors (public health agencies, communities, organizations, academia, and medicine) to take actions to strengthen policies and improve practices that are driven by the best available evidence and knowledge. The Healthy People 2010 objective for COPD called for a 50% reduction in the mortality rate from COPD among adults aged ≥ 45 years at baseline in 1999 (123.9 per 100,000)^[@r36]^; however, that objective was not met by 2010 (116.6 per 100,000)---possibly for many reasons described above. The new Healthy People 2020 effort^[@r37]^ has been expanded to include the following objectives that pertain to the evaluation and management of COPD among adults aged ≥ 45 years:• Reduce activity limitations among adults with COPD.• Reduce deaths from COPD.• Reduce hospitalizations for COPD.• Reduce hospital ED visits for COPD• Increase the proportion of adults with abnormal lung function whose underlying obstructive disease has been diagnosed.

The CDC and the National Heart Lung Blood Institute (NHLBI) have a formal collaboration to increase public awareness and identify critical communication, research, evaluation, and data collection needs to prevent and manage COPD. This collaboration has resulted in the annual BRFSS collection since 2011 of COPD prevalence data at state and local levels, which will enhance the COPD Learn More Breathe Better Campaign supported by the NHLBI. Such state-level and county-level data as the BRFSS, Medicare, and vital statistics can identify geographic clustering of, as well as racial/ethnic disparities in, COPD indicators to provide guidance to public health agencies in leveraging and targeting resources to those geographic areas and local populations with the greatest burden of COPD. These data will also be critical in identifying communities that will likely benefit best from awareness and outreach campaigns and in evaluating the effectiveness of public health efforts to prevent, treat, and control COPD.

COPD remains a significant source of morbidity and mortality in the United States. In 2007, chronic lower respiratory diseases constituted the fourth leading cause of death and rose to the third leading cause of death in 2008 primarily because cerebrovascular disease deaths continued a consistent decline and to a lesser extent as a result of adjustments to coding and classification.^[@r1]^ The data examined in this surveillance report testify to the heavy public health burden that COPD continues to levy in the United States. Prior to 1999, rates of mortality and hospitalizations had shown worrisome increases. Thus, the apparent leveling of the mortality rate and a decrease in the rate of hospitalization represent cause for cautious optimism. Future surveillance efforts will be critical to tracking the course of COPD in the United States.
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